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Testing a Model of Health-Related Quality of Life in Women Living with HIV Infection 
Nahed Alsayed, PhD 
University of Pittsburgh, 2015 
The diagnosis of HIV infection in women may adversely affect their health and their health-
related quality of life (HRQoL).  At present, research about women living with HIV infection 
and the multiple factors that contribute to their HRQoL is limited.  The purpose of this study was 
to test the revised model of HRQoL by Wilson and Cleary (Ferrans et al., 2005) using a 
secondary analysis of baseline data from 178 women who participated in two independent 
randomized controlled studies.  This linear model includes inter-related components (biological 
function, symptoms, functional status, and general health perceptions) which lead ultimately to 
HRQoL.  The primary aim was to examine the relationships among the five components of the 
model.  The secondary aim was to examine the relationships among the individual (i.e. age, 
children, race, marital status, education) and environmental (i.e. HIV-related stigma, social 
support) characteristics that may impact biological function, symptoms, functional status, general 
health perceptions, and overall HRQoL among women living with HIV infection.  Observed 
variables included:  biological function (CD4 count and viral load), symptoms (depressive 
symptoms and energy/fatigue), functional status (physical and social functioning), general health 
perceptions (overall general health and mental health), environmental factors (social support and 
HIV-related stigma), and HRQoL (satisfaction with life and overall quality of life).  Structural 
equation modeling (SEM) and path analysis were performed on multiple path models to examine 
the hypothesized multivariate relationships proposed in the revised Wilson and Cleary model of 
HRQoL (Ferrans et al., 2005). Originally, a latent path model was planned. Due to problems with 
the measurement model, the latent path model was simplified and observed and hybrid path 
models were created. While the two main models for the primary and secondary aims did not fit 
well, post hoc modified models adding a path from symptoms to general health perceptions 
provided an adequate model fit.  Women with lower viral loads, lower depressive symptoms, 
lower HIV-related stigma, higher social support, higher physical functioning, and higher general 
health perceptions had higher overall HRQoL. The results of this study have the potential to 
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assist healthcare professionals in improving health-related quality of life for women living with 
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An estimated 35.3 million people worldwide are currently living with human immunodeficiency 
virus (HIV) or acquired immunodeficiency syndrome (AIDS) (UNAIDS, 2013).  Globally, HIV 
is a debilitating, difficult to manage, infectious disease which often results in AIDS, and then 
death.  In 2013, 2.1 million people worldwide were newly diagnosed with HIV; 1.5 million 
people died from AIDS (World Health Organization, 2014a). In the United States, 1.2 million 
people are currently living with HIV/AIDS (Centers for Disease Control and Prevention [CDC], 
2014a).  In 2012, almost 50,000 people were newly diagnosed with HIV and in 2011 nearly 
14,000 people died from AIDS, with a cumulative death toll of almost 650,000 people in the 
United States (US) since the start of the epidemic (CDC, 2014a; CDC, 2014b). 
Worldwide, HIV is mainly transmitted through sexual intercourse and intravenous drug 
use.  In 2012, 90 percent of people in the United States were infected through sexual intercourse 
and only 7 percent through intravenous drug use (CDC, 2014b). While men who exclusively 
have sex with men (MSM) are the largest risk group in the United States, comprising 47.1% of 
the total number of people living with HIV/AIDS, women who have sex with men (WSM) 
comprised 26.7% of the total number living with HIV/AIDS as of 2009 (Blair et al., 2014). 
HIV/AIDS has become a chronic disorder due to medical advances, new drug therapies, 
and improved methods of care.  By the end of 2013, 12.9 million people worldwide were 
receiving antiretroviral treatment (ART), with two million people with HIV/AIDS being newly 
enrolled in ART in 2013, a record-breaking year (WHO, 2014b).  As of 2010, 363,000 people in 
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the United States were in treatment for HIV/AIDS, representing only 33% of the total number of 
people living with HIV in the United States (CDC, 2014b).  Survival rates have dramatically 
improved with the widespread use of ART.  Life expectancy has increased from 36.1 years in 
2000-2002 to 51.4 years in 2006-2007 (Samji et al., 2013).  
 The fact that people with HIV/AIDS are living longer has led to a shift of classification of 
the infection from an acute disease to a chronic disorder (Hickner, 2014).  Managing treatment 
for a chronic disorder can be burdensome and challenging.  People living with HIV/AIDS have 
special needs associated with their diagnosis including needing constant treatment, living with its 
side effects, and getting long-term follow-up.  While ART provides maintenance for the disease, 
it also has very high toxicity that might cause other health problems.  Other challenges associated 
with living with HIV/AIDS include limited access to medical care in an overburdened health 
care system, financial considerations, HIV stigma, and mental health issues (Aranda-Naranjo, 
2004; Chu & Selwyn, 2011; Deeks et al., 2013; Palmisano & Vella, 2011).  Together these 
challenges have an impact on an individual’s overall health-related quality of life (HRQoL). 
 According to the World Health Organization (WHO), quality of life (QoL) is defined as 
“individuals’ perception of their position in life in the context of the culture and value systems in 
which they live and in relation to their goals, expectations, standards and concerns” (Herman et 
al., 1998, p. 1570). HRQoL “refers to how health impacts an individual’s ability to function and 
his or her perceived well-being in physical, mental, and social domains of life” (Coons et al., 
2000, p. 14).  HRQoL is a more specific construct generally defined as a subjective evaluation of 
one’s life along a number of dimensions relating to an individual’s health (Herman et al., 1998).  
QoL and HRQoL are conceptually different, yet both aim to assess an individual’s health and 
overall well- being.  In the nursing and public health literature, QoL and HRQoL are used 
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interchangeably, oftentimes within the same studies.   Therefore, QoL and HRQoL will be used 
interchangeably throughout this report. 
 Research examining HRQoL of persons across the continuum of HIV has primarily been 
limited to the evaluation of the effectiveness of medical and pharmacological treatments for HIV 
largely in men (Lorenz et al., 2001; Lubeck & Fries, 1997; Mrus et al., 2005).  However, there is 
growing recognition that for persons (both men and women) with HIV, HRQoL is an important 
outcome in itself; predictors include psychological and social factors such as depressive 
symptoms, HIV stigma, and social support (Andrinopoulos et al., 2011) and physiological factors 
such as CD4 count and viral loads (Basavaraj et al., 2010). 
 
1.1 SIGNIFICANCE OF THE PROBLEM: WOMEN, QUALITY OF LIFE, AND HIV 
 
HIV/AIDS is the number one cause of death in women of reproductive age (Ribeiro, 2008). By 
the end of 2011, over 220,000 women in the US were living with HIV/AIDS (CDC, 2014a).  The 
Center for Disease Control and Prevention (CDC) has estimated that women now represent about 
25% of the total number of people living with HIV/AIDS (CDC, 2014a).  The CDC has also 
reported that the majority of women (84%) who contract HIV do so through heterosexual contact 
(CDC, 2014a).  Women are more susceptible to contracting HIV than men during unprotected 
vaginal sex (CDC, 2014c).  Transmission of the infection from men to women during 
heterosexual intercourse is eight times more likely to occur than from women to men (Floridia et 
al, 2008).  Additionally, women have different physical complications from HIV infection 
compared to men, such as vaginal yeast infections, pelvic inflammatory disease, and human 
papillomavirus (HPV) (NICHD, 2013).  
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Women also have different emotional complications from HIV, compared to men.  
Women are more likely to suffer from moderate to severe depression (Loutfy et al., 2013).  
Women living with HIV must also attempt to maintain support systems and manage HIV stigma.  
This can be difficult because of negative societal perceptions of individuals living with HIV.  
Understanding the effects of HIV on a woman’s ability to maintain her functional status is 
imperative.  Research has shown that women living with HIV have a lower overall HRQoL than 
men (Mrus et al., 2005; Vigneshwaran et al., 2013).  Preserving a woman’s self-image and 
HRQoL is critical. 
Multiple factors impede women from receiving treatment for HIV and seeking the 
mental, emotional, psychological, and financial support of others (Clum et al., 2013).  Women 
often balance multiple roles within the family, such as wife, mother, caregiver, and support to 
other family members (Edwards, Irving, & Hawkins, 2011).  Children without a mother's 
emotional support may do poorly in school and exhibit emotional disturbance.  Therefore, the 
impact of HIV on women can negatively affect family systems. Further, women who cannot 
fulfill responsibilities within the family and/or maintain independence can adversely affect both 
the family and societal economy with a decline in workforce productivity and an increased need 
for social services, such as disability benefits (Marini & Stebnicki, 2012).  Thus, women living 
with HIV must be helped to manage their HIV in order to maintain and improve their HRQoL 
(Andrinopoulos et al., 2011).  Current HIV research is beginning to focus more on women living 
with HIV/AIDS; however, researchers have a limited understanding of the various unique 
obstacles faced by women with this disease.  Due to the lack of literature on the factors 
influencing the HRQoL of women living with HIV/AIDS, there is a need for more research 




1.1.1 Model overview 
 
Although some research has been conducted with women living with HIV in the US, there are 
limited findings that show a clear understanding of the factors that contribute to women's 
HRQoL. Multiple models have been constructed to explain HRQoL.  Three examples include: 
Wilson and Cleary conceptual model of HRQoL (1995), revised Wilson and Cleary (Ferrans et 
al., 2005), and the World Health Organization International Classification of Functioning, 
Disability, and Health (WHO ICF) (2014) (Bakas et al., 2012). 
The WHO ICF “provides a standard language and framework for the description of 
health and health-related states” (WHO, 2002, p. 2).  This model was designed to measure the 
level of an individual’s function in society as a whole, regardless of the reasons for an 
individual’s disability.  Originally created in 1980, the WHO ICF model has evolved to focus on 
the impact of health-related issues as opposed to the causes of disease (Bakas et al., 2012).  The 
WHO ICF model is considered to be a “biopsychosocial model,” combining both medical and 
social models of disability and therefore encompassing different aspects of health (e.g. 
biological, individual, and social) (WHO, 2002).  The components in the WHO ICF model 
(represented in Figure 1) include:  Body Functions and Structure, Activity, Participation, 




Figure 1. World Health Organization Model of International Classification of Functioning, Disability, and Health 
 
Wilson and Cleary (1995) developed a model that combines health beliefs from the 
medical and social sciences and shows how various patient outcomes are related.  This model 
explains an individual's HRQoL in terms of a number of components that are causally linked 
(represented in Figure 2).  The components of the model include:  Biological and Physiological 
Variables, Symptom Status, Functional Status, General Health Perceptions, Characteristics of the 





Figure 2. Wilson and Cleary Model of Quality of Life (1995) 
 
Ferrans et al. (2005) created a revised version of the Wilson and Cleary (1995) model of 
HRQoL.  Like the Wilson and Cleary (1995) model, Ferrans et al. (2005) proposed causal paths; 
however, the components of the model and their relationships are slightly different.  In this 
revised model the components include:  Biological Function, Symptoms, Functional Status, 
General Health Perceptions, Characteristics of the Individual, Characteristics of the 
Environment, and Overall QoL (represented in Figure 3).  In this model, Wilson and Cleary’s 
(1995) “Biological and Physiological Variables” were changed to “Biological Function” and the 
component “Nonmedical Factors” was removed.  According to Ferrans et al. (2005), there was 
no need to include “Nonmedical Factors” as an independent component because these factors 
can be attributed to either individual or environmental characteristics.  The name of the first 
component of the model was changed to “Biological Function” because “alterations in biological 
function directly or indirectly affect all components of health, including symptoms, function 




Figure 3. Revised Wilson and Cleary Model of Health-Related Quality of Life (Ferrans et al., 
2005) 
 
While all three models take into account various physical and psychological factors that 
influence an individual’s HRQoL, each model expresses the components and their relationships 
differently.  Wilson and Cleary (1995) failed to give examples of characteristics of the 
environment and individual.  Ferrans et al. (2005), on the other hand, added to the Wilson and 
Cleary (1995) model by including detailed explanations of the environmental and individual 
constructs and incorporating “Nonmedical Factors” into these components.  Another weakness of 
the Wilson and Cleary (1995) model is that individual and environmental characteristics do not 
contribute to “Biological and Physiological Variables,” whereas both the revised Wilson and 
Cleary and the WHO ICF models clearly indicate these associations.  In the WHO ICF model, 
“Environmental” and “Personal Factors” are linked with “Body Functions and Structure” (WHO, 
2002).  Ferrans et al. (2005) built upon the Wilson and Cleary (1995) model by acknowledging 
that the severity of disease is influenced by both individual and environmental characteristics and 
added paths to indicate these associations. 
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The conceptual framework of the WHO ICF is very flexible making the model 
translatable across many disciplines and applicable to people of different regions and cultures 
(WHO, 2002).  The model can be used internationally, even for children and youth, and can 
easily be understood by heath care workers, researchers, policy-makers, and the public (WHO, 
2002).  While the WHO ICF is a broad model that can be applied to multiple health conditions, it 
is not specific to HRQoL as are the Wilson and Cleary (1995) model and the revised Wilson and 
Cleary model (Ferrans et al.,2005).  The integration of biological and psychosocial factors and 
their effects on HRQoL is important in the context of HIV.  HRQoL is the main outcome 
variable in both the Wilson and Cleary model (1995) and the revised Wilson and Cleary model 
(Ferrans et al., 2005), making these models superior to the WHO ICF for HRQoL focused HIV 
research.  Although Wilson and Cleary’s (1995) model provided the foundation, the revised 
model is a more current and useful model for assessing HRQoL in people living with HIV/AIDS. 
Thus, the theoretical framework chosen for this study is based on the revised Wilson and 
Cleary model of HRQoL (Ferrans et al., 2005).  The model provides a direct causal path of the 
following: biological function, an assessment of symptoms, functional status, an individual's 
perception of her general health, and HRQoL as the outcome variable (Ferrans et al., 2005).  
According to Wilson and Cleary, the factors in the model can have inter-relationships “at every 
level of the model, although they are not represented in the Figure” (Wilson and Cleary, 1995, p. 
63).  This can also be said about the model by Ferrans et al. (2005) because the revised model 
adopted the same fundamental concepts as the original.  Assessing these relationships as they 
pertain to women may provide insight into gender-specific challenges of people living with HIV.  
Further, findings have the potential to improve the health outcomes of this population.  This 
study testing the revised model of Wilson and Cleary (Ferrans et al., 2005) is important because 
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it adds to the current knowledge and understanding of the basic components which affect the 





1.2 PURPOSE OF THE STUDY 
 
The overall purpose of this study was to test the revised Wilson and Cleary model of HRQoL 
(Ferrans et al., 2005) in order to better understand the components that influence HRQoL for 
women living with HIV.  Examining this topic has created a novel conceptualization within 
HRQoL theory to improve patient-centered outcomes and care interventions for women living 
with HIV.  This study was unique because it focused solely on women in the United States, a 
population that has been absent from much of the literature.  The findings of this study have the 
potential to benefit women living with HIV/AIDS by serving as foundational evidence to create 
interventions to improve HRQoL for this population. 
 
1.3 RESEARCH AIMS 
1.3.1 Primary aim 
 
The primary aim of this study was to examine the relationships among the five central 
components of the revised Wilson and Cleary (Ferrans et al., 2005) model (biological function, 
symptoms, functional status, general health status, overall quality of life). 
 
1.3.2 Secondary aim 
 
The secondary aim was to examine the relationships among the individual (i.e. age, children 
status, race, marital status, education) and environmental (i.e. HIV stigma, social support) 
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characteristics that may impact biological function, symptoms, functional status, general health 
perceptions, and overall quality of life among women living with HIV infection. 
 
1.4 DEFINITION OF TERMS 
 
1.4.1 HIV/AIDS 
Human immunodeficiency virus (HIV) is an infection transmitted by an exchange of bodily 
fluids, such as blood, semen, and breast milk (CDC, 2015a).  HIV attacks the immune system by 
destroying CD4 cells (i.e. T cells).  As CD4 cells are compromised, the body can no longer fight 
off infection.  Three stages of HIV have been identified: acute infection, clinical latency, and 
HIV-stage 3, also called acquired immunodeficiency syndrome (AIDS).  Currently, there is no 
cure for HIV (CDC, 2014d). 
 
1.4.2 Biological function 
 
Biological function refers to the physical state of the individual (Wilson & Cleary, 1995; Ferrans 
et al., 2005) and includes any measurable descriptor used to classify the biological status.  In 
HIV/AIDS biological function can be measured by CD4 cell count, viral load, and other clinical 
indicators that help to monitor the progression of HIV infection.   Biological function, as a 







Symptoms refers to the psychosocial, emotional, or cognitive state the individual is experiencing 
at the time of evaluation (Ferrans et al., 2005; Wilson & Cleary, 1995).  Depressive symptoms 
and fatigue were selected to represent symptoms in this study. 
 
1.4.4 Functional status 
Functional status refers to an individual's ability to perform specific tasks (Ferrans et al., 2005; 
Wilson & Cleary, 1995).  These tasks may include grocery shopping, keeping medical 
appointments, or balancing a checkbook.  Physical functioning and social functioning were 
chosen to represent functional status in this study. 
 
1.4.5 General health perceptions 
 
General health perceptions describe an individual's perception of one’s own health status based 
on the person’s biological, symptom, and functional status (Ferrans et al., 2005; Wilson & 
Cleary, 1995).  In this study, mental health as a construct follows the definition by Hays et al. 
(1995):  mental health encompasses depression and emotional issues, anxiety, nervousness, and 
happiness/sadness.  In this study general health and mental health were identified as the 





1.4.6 Overall quality of life 
 
Overall QoL refers to how satisfied an individual is with life and is often used as an outcome in 
clinical trials (Ferrans et al., 2005; Wilson & Cleary, 1995).  “Life satisfaction includes the 
individual’s appraisal of dimensions that go beyond health and function and takes into 
consideration the individual’s degree of happiness in relation to his or her beliefs, values, and 
needs in multiple life domains” (Eller & Mahat, 2007, p 19).  QoL and satisfaction with life were 
selected to represent a subject’s overall QoL. 
 
1.4.7 Characteristics of the individual 
 
Characteristics of the individual pertain to factors or correlates that contribute to defining a 
person's life situation (Ferrans et al., 2005).  These include demographic descriptors.  The 
characteristics of the individual for this study included age, children status, race, marital status, 
and education.  These are factors which may impact biological function, symptoms, functional 
status, general health perceptions, and overall QoL. 
 
1.4.8 Characteristics of the environment 
 
Characteristics of the environment refer to factors outside of the individual which may impact 
biological function, symptom status, functional status, general health perceptions, and overall 
HRQoL. They address the individual’s interactions with others as a member of society (Ferrans 
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et al., 2005).  In this study, the characteristics of the environment that were examined were HIV-
related stigma and social support. 
 
2.0 LITERATURE REVIEW 
This chapter reviews the literature and presents what is known about the relationships within the 
revised Wilson and Cleary model of health-related quality of life (HRQoL) (Ferrans et al., 2005) 
and about women living with HIV.  Literature was searched using the NCBI (National Center for 
Biotechnology Information, a research tool of the National Library of Medicine at National 
Institutes for Health) to access the following databases:  PMC (PubMed Central for life sciences 
journal literature), PsycInfo (literature of the American Psychological Association), and Pubmed 
(which includes the full content of MEDLINE for biomedical journal literature).  The keywords 
used in the search included:  quality of life, health-related quality of life, satisfaction with life, 
model of QoL, women and HIV, viral load, CD4 count, depressive symptoms, fatigue, pain, 
physical functioning, social functioning, mental health, overall health, social support, HIV 
stigma, age, children, education, marital status, and race. This chapter discusses factors 
influencing HRQoL, relationships within the revised Wilson and Cleary model of HRQoL 
(Ferrans et al., 2005), and factors affecting women living with HIV.   
 
2.1 FACTORS AFFECTING WOMEN LIVING WITH HIV 
 
HIV permeates multiple aspects of a person’s life: physical, mental, and emotional (NINDS, 
2014; Dalmida, 2006; Edwards, 2006). The literature about women living with HIV addresses a 
wide-range of topics from mother-to-child transmission of HIV (Walcott et al., 2012) to 
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medication adherence (Erlen et al., 2002), and includes women who are married and single.  For 
example, married women attempting to manage their HIV reported less satisfaction with 
receiving support from their husbands (Edwards & Hawkins, 2011).  Edwards and Hawkins 
(2011) found that married women neglected their own health regimen to take care of their HIV 
infected husbands.  This literature review focuses on topics highly relevant to HRQoL of women 




Disclosure is an integral part of the adjustment process of accepting and living with HIV and is a 
link to preventing the spread of HIV infection (Hult et al., 2012).  Disclosure of HIV serostatus 
can be difficult for women.  Many must consider the perceptions of intimate partners, friends, 
family, and the community once their HIV status becomes known (Clum et al., 2013; Nyblade et 
al., 2009; Swendeman et al. 2006).  Serovich et al. (2012) found that in a sample of 125 women 
living with HIV, almost 50% of intimate partners and family members were told of the diagnosis 
within the first month of diagnosis.  Nevertheless, the fear of disclosing their condition can 
prevent them from receiving medical assistance from healthcare professionals and receiving the 
psychological and financial support of others, which can in turn affect their HRQoL (Kalichman 
& Grebler, 2010; Serovich et al., 2012; Wolitski et al., 2009).  In a longitudinal study with 
individuals newly diagnosed with HIV, Hult et al. (2012) interviewed 50 people (8% women) 
living with HIV/AIDS (PLWHA) and found that approaches to disclosure were affected by life 
context and that PLWHA perceived HIV disclosure as either a stressor or a stress-coping 
mechanism.   
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Challenges of disclosure also include maintaining privacy.  Peterson (2010) interviewed 
45 women living with HIV and reported that they were concerned that disclosing to family 
would mean that others would find out about their HIV status.  They feared that family would 
not keep their diagnosis private.  Nondisclosure can be problematic for women living with HIV, 
as disclosure is needed to access HIV health services and social support.  Fear of stigma is a 
primary reason for nondisclosure, leading to multiple challenges for women attempting to 




Stigma is most often defined as an “attribute that is deeply discrediting,” reducing someone 
“from a whole and usual person to a tainted, discounted one” (Goffman, 1963, p. 3).  In HIV 
health care, stigma is often intertwined with discrimination carried out by health care workers 
and manifested by differential treatment, denial of care, disclosure of HIV status without consent 
(to family members or others), verbal abuse, gossip, and neglect (Nyblade et al., 2009).  Women 
with HIV must learn to manage such negative encounters. 
In a sample of 183 participants, Colbert et al. (2010) found that women reported higher 
levels of stigma than men on all four subscales of Berger’s HIV Stigma Scale:  personalized 
stigma (p < 0.001), disclosure (p = 0.001), negative self-image (p = 0.001), and perceptions of 
public attitudes (p < 0.001).  One reason for higher stigma in women is that stereotypes related to 
HIV differ by gender– women are labeled as promiscuous while men are labeled as homosexuals 
(Sayles et al., 2007).  Stigma can marginalize a woman and hinder her from achieving her fullest 
potential.  Perceived stigma can cause a woman to become mentally and emotionally paralyzed.  
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The threat of becoming socially marginalized, abandoned, and losing close partners can be 
overwhelming and can bring about low self-esteem (Sengupta et al., 2011).   
In a qualitative study Peterson (2010) interviewed 45 women between 19 to 64 years old 
who were primarily African American (80%) and found that fear of stigma prevented them from 
seeking HIV information and social support.  Moreover, isolation, depressive symptoms, and low 
medication adherence were identified as outcomes of perceived HIV stigma (USDHHS, 2012).  
As a result, women with HIV often avoid getting the treatment that they need (Peterson, 2010).   
When a woman perceives that she is being stigmatized, those feelings are often internalized 
(whether or not the stigma she experiences is actual or perceived) and can have a destructive 
effect (Sengupta et al., 2011). Furthermore, the woman does not seek the continued support 
necessary to successfully carry out the demanding HIV care regimen. 
Although women living with HIV often feel stigmatized, many welcome and appreciate 
interactions with individuals and groups interested in their plight and the challenges that they 
face.  In a pilot study involving 24 African American women, Rao et al. (2012) tested a new 
intervention through a workshop led by an HIV-positive African American woman.  Subjects 
who participated in this peer-led workshop showed decreased levels of internalized stigma (p = 
0.05) (Rao et al., 2012).  This finding suggests that under comfortable circumstances, women can 
be helped to manage their disease and reduce perceived stigma. 
As HIV progresses fulfilling work responsibilities becomes a challenge for women living 
with HIV (Webel & Higgins, 2012).  Webel and Higgins (2012) interviewed 48 women living 
with HIV of whom only 20% were employed.  One Caucasian participant reported that after 
disclosing her HIV serostatus to an employer, she was not fired but they made her “time there 
miserable” (Webel & Higgins, 2012, p. 7).   Working women with HIV agreed that they 
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intentionally chose jobs that would allow them to avoid having to disclose their HIV serostatus.  
Multiple researchers have reported in their studies that the more than 50% of women with HIV 
were unemployed (Colbert et al., 2010; Messer et al., 2013; Psaros et al., 2012; Vyavarharkar et 
al., 2012; Webel & Higgins, 2012). 
 
2.1.3 Mental Health 
 
PLWHA are living longer because of highly active anti-retroviral therapy (HAART); 
nevertheless, they struggle with the physical and emotional challenges associated with the 
disease.  For a sample of 914 men and women, 50 years or older, Grov et al. (2010) reported that 
in addition to HIV stigma, mental health issues such as major depressive symptoms and 
loneliness were interrelated, pervasive, and enduring components associated with living with 
HIV.  However, this study did not find that women were more likely to have major depression 
than men (38.7% and 39.2%, respectively) (Grov et al., 2010). Walsh et al. (2012) examined the 
experiences, needs, and internet use of 20 women newly diagnosed with HIV using a telephone 
interview format.  This study concluded that newly diagnosed women should be referred to 
mental health services early in their treatment as these researchers found that newly diagnosed 
women were more likely to perceive HIV stigma than those who had been living with HIV 
infection for a number of years.  Early health care support could help to close the gap between 
new diagnoses and entry into health care treatment.  Walsh et al. (2012) suggested that waiting 
for this population to acquire the level of coping skills and illness acceptance on their own would 
ultimately decrease their QoL because they are less likely to seek and stay in treatment. 
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 Isolation, as a depressive symptom, is another major challenge with which women with 
HIV must contend (Grov et al., 2010).  When a woman is diagnosed with HIV, the 
embarrassment and shame associated with this disease may cause her to lose touch with her 
friends and family.  Because of depressive symptoms, an HIV infected woman will likely isolate 
herself from others, which will directly or indirectly affect family members, friends and 
coworkers (Hult et al., 2012).  Another form of isolation comes with caretaking.  In a qualitative 
study of five married HIV positive African American women, Edwards et al. (2011) found that 
women who assumed the responsibility of caretaker for their husbands felt isolated and 
sacrificed their own QoL to care for their sick spouses.  In another qualitative study by Edwards 
(2006), 20 HIV positive African American women were interviewed in order to assess the effect 
of social support on medication adherence.  Surprisingly, women with children reported that 
their kids were their main source of social support as opposed to being a burden. 
 
 
2.1.4 Quality of Life 
 
The literature addressing QoL of women living with HIV has increased in the last several years.  
However, there has been conflicting evidence when comparing QoL between men and women.  
Mrus et al. (2005) conducted a study designed to simultaneously assess gender differences and 
compare ART regimens.  In this clinical trial, 202 females and 976 males in the United States 
and Puerto Rico were randomly assigned to a drug regimen, and their HRQoL was monitored at 
baseline, 24 weeks, and 40 weeks (Mrus et al., 2005).  HRQoL was measured using the AIDS 
Clinical Trials Group (ACTG) QoL Survey, a modification of the Medical Outcomes Study.  At 
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every time point, women expressed lower QoL than men on nearly every domain measured 
(Mrus et al., 2005).  However, the only statistically significant domain was in mental health (p = 
0.046) (Mrus et al., 2005).  In contrast, Feinberg et al. (2011), using the Functional Assessment 
of HIV Infection (FAHI) survey to measure HRQoL in a randomized controlled trial of 193 
women and 142 men from the United States, Canada and Puerto Rico, found that while women 
had slightly lower HRQoL scores than men at baseline (not statistically significant), they had 
greater improvement in HRQoL than men over the 48 week time period.  .  Further, in a cross-
sectional study of 60 men and 60 women in rural India, Vigneshwaran et al. (2013) found using 
the MOS-HIV Health Survey that women scored lower than men on both overall HRQoL 
(women 43.6, men 54.6, p < 0.0001) and perceived QoL (women 43.8, men 65.4, p < 0.0001).  
These conflicting results may have been due to physiological and psychological factors unique to 
women that affect their QoL.  Women are more susceptible than men to mental illness such as 
mood and anxiety disorders and depression which could lead to lower overall QoL (Linzer et al., 
1996).  Another explanation for these conflicting results might be that the researchers used 
different instruments to measure HRQoL. 
 
2.2 FACTORS INFLUENCING HRQOL 
 
The revised model of HRQoL by Wilson and Cleary (Ferrans et al., 2005) addresses five 
domains: biological function, symptom status, functional status, general health perception, and 
overall quality of life (see Figure 3).  In addition, this model suggests that the environment and 
the individual characteristics (and circumstances) of a person exert a significant impact on one’s 




2.2.1 Biological function 
 
Measurements of biological function are medical indicators of health.  These measurements are 
“molecular, cellular, and whole organ level processes” (Ferrans et al., 2005, p. 338) including 
clinical data such as CD4 count, viral loads, and weight loss.  Physiological factors are a 
patient’s first indication of illness, measured and reported by his or her physician.  Higher CD4 
count and lower viral loads are good indicators for better health and are associated with higher 
general health status (Clingerman, 2003).  Physiological factors such as disease progression, 
CD4 count, and viral load are not only clinical indications of disease severity, but also are 
associated with a patient’s HRQoL (Basavaraj et al., 2010; Vyavaharkar et al., 2012).  Higher 
CD4 count and lower viral loads have been associated with higher QoL (Ruiz-Perez et al., 2005; 
Armon et al., 2012). Women who had a CD4 count higher than 200 were more likely to have a 
higher QoL (McDonnell et al., 2000).   
Baseline biological function has also predicted both positive changes (Lorenz et al, 2006) 
and negative changes (Feinberg et al., 2011) in QoL over time during drug treatment studies. In 
an 18-month longitudinal study assessing HIV treatment and HRQoL changes, Lorenz et al. 
(2006) analyzed 2267 data for men and women and found that patients with CD4 count over 200 
had greater improvements in overall health. In this study, Lorenz et al. (2006) measured HRQoL 
using a single question:  “How would you rate your quality of life, overall?”   However, using 
data from the GRACE (Gender, Race, And Clinical Experience) study, Feinberg et al. (2011) 
found that lower baseline CD4 count predicted improvements in HRQoL.  CD4 count was only 
measured at baseline. 
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Biological functions, such as disease progression, CD4 count, and viral load, play a role 
in a patient’s physical and emotional symptoms in addition to HRQoL.  Disease severity can lead 
to psychological complications such as depression, fear, and anxiety.  Chronic depressive 
symptoms have been associated with lower CD4 cell count and higher mortality rates (Ickovics 




Symptoms are the expression of a disease on a patient’s physiological and psychological status.  
According to Ferrans et al. (2005), symptom status most commonly refers to “frequency, 
intensity, and distress” (p. 339).  Symptoms can be either physical or mental.  Physical 
symptoms include but are not limited to fatigue and pain.  Fatigue is “tiredness that is unrelieved 
by a full night of sleep” (Jenkin et al., 2006, p 1124).  Psychological symptoms include but are 
not limited to fear, worry, and depression.  Vance et al. (2010) found that there are higher levels 
of depression among people living with HIV than in the general population. 
 HIV-related symptoms, both mental and physical, contribute to a lower QoL (Basavaraj 
et al., 2010; Phaladze et al., 2005; Vyavaharkar et al., 2012).  In a study of 743 men and women 
in sub-Saharan Africa, patients who expressed more severe HIV-related symptom intensity 
(measured by the Revised Sign and Symptom Checklist for Persons with HIV Disease) had 
lower overall satisfaction with life (p = 0.01) (Phaladze et al., 2005).  In the aforementioned 
longitudinal study by Lorenz et al. (2006), participants who had fewer total symptoms (p < 
0.001) and higher overall QoL (p < 0.001) at baseline had higher QoL at the end of the study.  In 
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the same study, patients who had worsening symptoms over time showed significant decreases in 
overall health (p < 0.001) and QoL (p < 0.001) (Lorenz et al., 2006).  
Patients with higher levels of depressive symptoms (Andrinopoulos et al., 2011; 
Vyavaharkar et al., 2012) and symptom intensity (Phaladze et al., 2005) had lower baseline QoL 
and also showed a decrease in QoL over time (Lorenz et al., 2006).  In a cross-sectional study 
conducted by Vyavaharkar et al. (2012) on 399 women from the rural southeastern United States, 
depressive symptoms were associated with lower levels of QoL (r = -0.34, p < 0.05).  In a 
longitudinal study of 179 young women (ages 15 to 24 years), Andrinopoulos et al. (2011) found 
that the occurrence of serious clinical depression was associated with lower levels of satisfaction 
with life (p < 0.001).  People who suffered from depression were also found to have higher 
fatigue (Barroso et al., 2013; Voss, 2005).  
HIV-related symptoms can prevent women living with HIV/AIDS from participating in 
their daily activities and social engagements.  Researchers have shown that patients who 
experience fatigue (Barroso et al., 2010) or physical limitations (McReynolds, 1998) were more 
prone to depressive symptoms. Women with lower physical (r = -0.44, p < 0.01) and lower social 
(r = -0.61, p <0.01) functioning had higher levels of depression (Eller & Mahat, 2007).  White et 
al. (2012) also found that less physical functioning was associated with more depression.  In the 
same study, participants with higher physical functioning and better problem solving showed 





2.2.3 Functional Status 
 
Functional status is one’s ability to participate in day-to-day activities.  According to Wilson and 
Cleary (1995), there are four domains of functional status:  “physical function, social function, 
role function, and psychological function” (p. 61).  Functional status includes physical activity, 
energy levels, and performance of everyday tasks.  Higher levels of functioning indicate better 
overall general health. 
 Physical functioning refers to everyday physical activities, while social functioning 
represents everyday social activities.  According to Basavaraj et al., “many people living with 
HIV/AIDS find it challenging to attend to daily tasks of living, participate in moderate to 
vigorous physical activities, or have sufficient energy or vitality to engage in an active social life 
while managing HIV/AIDS” (2010, p. 76).  People living with HIV, who had better overall 
functioning (Phaladze et al., 2005), and who participated in frequent physical activity (r = 0.49, p 
< 0.01) (Clingerman, 2004), had a higher overall QoL than their less active counterparts.   In a 
study of 98 HIV-positive Nepali women, both social functioning (r = 0.47, p <0.01) and physical 
functioning (r = .32, p <0.01) had a significant relationship with satisfaction with life (Eller & 
Mahat, 2007).  Physical functioning was also positively correlated with QoL (Gielen et al., 
2001).  People living with HIV/AIDS who participated in more frequent physical activity also 





2.2.4 General Health Perceptions 
 
General health perceptions are a combination of biological function, symptom status, and 
functional status and are unique to each individual (Ferrans et al., 2005; Wilson & Cleary, 1995).  
General health perceptions are “an integration of all of the health concepts… as well as others 
such as mental health, and they are by definition a subjective rating” (Wilson & Cleary, 1995, p. 
62).  Better general health perceptions reflect a higher overall health as perceived by the 
individual.  
Overall general health and mental health have been associated with many of the factors 
that contribute to a person’s QoL.  Women who had higher general health perceptions had higher 
levels of physical functioning (Eller & Mahat, 2007).   Women with better mental health had 
greater satisfaction with life (Eller & Mahat, 2007).  Moreover, people who had increased social 
support had higher mental health scores (Degroote et al., 2014; Gielen et al., 2001) and better 
overall health perceptions (Cowdery & Pesa, 2002).  
 
2.2.5 Characteristics of the Individual and Environment 
 
Characteristics of the environment such as social support and HIV stigma may influence all 
aspects of a patient’s overall health.  HIV stigma is an end result of discrimination and has a 
negative impact on a person’s overall well-being.  Both perceived and internalized stigma have 
been shown to negatively affect QoL (r = -0.38, p < 0.05) in people living with HIV 
(Vyavaharkar et al., 2012).  
27 
 
While HIV-related stigma affects PLWHA’s overall QoL, it also affects many other 
aspects of their health.  Research has shown that patients who had higher HIV-related stigma 
exhibited more severe signs and symptoms and had lower overall physical health (Colbert et al., 
2010; White et al., 2012).  HIV-related stigma has also been shown to negatively affect a 
person’s psychological well-being.  People who showed signs of higher levels of HIV-related 
stigma had higher levels of depression (Clum et al., 2009; Logie et al., 2013; Vyavaharkar et al., 
2012; White et al., 2012).  Also, patients who did not show signs of depression had lower 
perceived HIV-related stigma (p < 0.0001) (Galvan et al., 2008).  White et al. (2012) conducted a 
cross-sectional study of 150 people living with HIV (20.7% women and 68.7% African 
American) to assess whether HIV-related stigma, social support, and problem-solving skills 
affected a patient’s depressive symptoms.  Their findings showed that there was a moderately 
strong positive relationship between HIV-related stigma and depressive symptoms (r = 0.54, p < 
0.01).  This study also found that patients with lower levels of HIV-related stigma displayed 
higher social problem solving (White et al., 2012). 
While HIV-related stigma is a negative environmental factor affecting a patient’s overall 
health, social support can have a strong positive impact on a patient’s life. Individuals with a 
high level of social support have better overall QoL (Andrinopoulos et al., 2011; Basavaraj et al., 
2010; Vyavaharkar et al., 2012).  Emotional support (Barger et al., 2009) and support from 
friends (Clingerman, 2004) are the most influential environmental predictors of higher overall 
QoL. 
Social support was found to not only improve a patient’s mental health (Cowdery & Pesa, 
2002), but also improve physical health, such as lower viral loads (Clingerman, 2003).   More 
social support was associated with more frequent levels of physical activity (Clingerman, 2003).  
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Patients who showed less severe signs and symptoms of HIV were more likely to have social 
support (r = -0.26, p < 0.01) (White et al., 2012).  People with more social support also had fewer 
depressive symptoms (Clum et al., 2009; Vyavaharkar et al., 2012; White et al., 2012).  In a 
study conducted by White et al. (2012), patients with better social support had higher levels of 
social problem solving.   Colbert et al. (2010) showed that social support significantly predicted 
physical health in women (b = 0.334, p = 0.003).   Furthermore, higher levels of social support, 
especially from friends (Galvan et al., 2008) were associated with lower levels of HIV stigma 
(Clum et al., 2009; Colbert et al., 2010; Logie et al., 2013; White et al., 2012).  A cross-sectional 
study by Galvan et al. (2008) examined the relationship between social support and HIV stigma 
in 283 HIV positive African American adults (25.8% female).  Social support from family (p < 
0.05) and friends (p < 0.001) significantly predicted lower HIV stigma (Galvan et al., 2008).   
Greater social support was also associated with better health perceptions in women (Cowdery & 
Pesa, 2002). 
Individual characteristics play an important role in the QoL of PLWHA.  Demographic 
variables such as race, age, and religious beliefs factor into a patient’s health.   A person’s race 
may determine how the body reacts to certain diseases including HIV/AIDS because of genetics.  
For instance, African Americans are more prone to diseases such as type 2 diabetes (CDC, 
2011).   In a six-month study with 423 HIV-positive homosexual men, Easterbrook et al. (1996) 
found that African American men had a slower CD4 count decline than white men.  Some 
studies have suggested that African American women have a higher QoL than white women 
(Mrus et al., 2005; Vyavaharkar et al., 2012).  In drug treatment studies of men and women, 
African Americans have shown greater improvement in HRQoL than Whites (Feinberg et al., 
29 
 
2011).  African Americans have also been shown to have more social support (Colbert et al., 
2010).   
The literature reports conflicting results on the relationship between age and QoL.  
Studies have shown a negative correlation between age and physical health (measured by the 
MOS-HIV scale) (p = 0.009) (Ruiz-Perez et al., 2005), a positive correlation between age and 
QoL (measured by the Chronic Illness Quality of Life Ladder) (r = 0.15, p < 0.01) (Vyavaharkar 
et al., 2012), and no significant correlation between age and QoL (measured using an adaptation 
of the Diabetes Quality of Life scale for youth) (p = 0.878) (Andrinopoulos et al., 2011).  Despite 
these conflicting findings, patients who were diagnosed with HIV more recently had a lower 
QoL (measured using the Chronic Illness Quality of Life Ladder) than those who were diagnosed 
in the past (Vyavaharkar et al., 2012).  A patient’s age may also influence physiological factors 
and symptoms, such as viral load, pain, and fatigue.  Age may also affect an individual’s 
response to the environment.  Older patients may have more established social support systems 
and less HIV stigma.  Regardless of a patient’s age, the length of time since diagnosis has been 
found to be associated with HIV stigma; for example, patients who were diagnosed more 
recently were found to have higher levels of HIV stigma (p < 0.05) (Galvan et al., 2008). 
Demographic characteristics based on life choices such as education, marital status, and 
having children can be expected to influence a woman living with HIV/AIDS; however, 
researchers have failed to agree on this issue.  Studies connecting education and QoL are 
conflicting.  Vigneshwaran et al. (2013) found that patients with more education had a 
significantly higher (p < 0.05) perceived QoL, while Andrinopoulos et al. (2011) found a 
positive trend that was not statistically significant between education and QoL (p = 0.056).  
Patients with higher education also have shown increased levels of overall health (Lorenz et al., 
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2006).  On the other hand, less educated individuals have been shown to have a higher 
satisfaction with life than their more educated counterparts (Phaladze et al., 2005).  More 
education is associated with both lower HIV stigma (Wagner et al., 2010) and better physical and 
work-role functioning (Vidrine et al., 2003).  In addition to a woman’s education, the choice to 
have children could also have an impact on a woman’s health.  In the context of women living 
with HIV, having children has not been found to affect QoL (Andrinopoulos et al., 2011); 
however, women with no children have been found to have higher levels of social support (Logie 




There is a paucity of literature examining women with HIV and their HRQoL, underscoring the 
need for this study.  This review of the literature has discussed factors influencing HRQoL and 
factors affecting women living with HIV.  The literature review has provided a foundation for 
this study testing the revised model of HRQoL by Wilson and Cleary (Ferrans et al., 2005) with 





The following chapter describes the methodology used in this study.  Here, a description of the 
parent study and the research design are introduced.  A detailed account of data collection and 
data management is described.  Next, all measures used in this study are defined and justification 
for sample size is explained.  Lastly, there is a section that specifies which statistical methods 
were employed to address the study aims. 
 
3.1 PARENT STUDIES 
 
3.1.1 Research Design of Parent Studies 
 
This study was a secondary analysis using baseline (i.e. pre-intervention) data pooled from two 
independent randomized controlled trials (R01 NR04749, Adherence to Protease Inhibitors and 
Quality of Life, and 2R01 NR04749, Improving Adherence to Antiretroviral Therapy, Principal 
Investigator, J. A. Erlen). The first parent study examined the efficacy of an intervention to 
enhance adherence to antiretroviral therapy (ART) in persons living with HIV (R01 NR04749, 
Principal Investigator, J. A. Erlen).  The intervention was a nurse-delivered, telephone-based, 
cognitive-behavioral program designed to enhance ART adherence.  Participants were randomly 
assigned either to the intervention plus usual care or usual care only.  The main aim of this parent 
study was to test the efficacy of the structured intervention compared to usual care on ART 
adherence over time.  The secondary aims of the study assessed relationships among ART 
adherence, health-related quality of life (HRQoL), and clinical response. 
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The second parent study was a continuation of the earlier clinical trial, adding an 
individualized intervention as a third treatment arm (2R01 NR04749, Principal Investigator, J. A. 
Erlen).  Subjects with HIV and taking ART were randomized to one of three treatment groups:  
structured intervention, individualized intervention, and usual care (control).  The structured 
intervention consisted of the same telephone-based adherence program from the first parent 
study and was considered to be a nurse-directed intervention approach and had a pre-defined 
order to the delivery of the intervention sessions.  In contrast, the individualized intervention, 
based on a subject’s needs, was considered to be a tailored intervention approach.  The primary 
aim of the second parent study was to test the efficacy of the structured and individual ART-
adherence interventions compared to usual care over time.   The secondary aim of this study, as 
in the first parent study, focused on testing the associations of ART adherence with clinical 




Inclusion criteria for both parent studies were the following:  HIV-infected individuals over 18 
years old who were currently taking antiretroviral therapy, with no cognitive dysfunction at 
baseline, who lived in a private residence in the community, spoke English, and had access to a 
telephone.  No individuals were excluded based on race, gender, or ethnicity.  Individuals who 
lived with someone already in the study, were not willing to use the electronic event monitor 
(EEM), had a hearing impairment and could not hear when using the telephone, were diagnosed 
with HIV dementia, were blind, or had motor impairment in their upper extremities were 
excluded.  In the second study, individuals who were in the treatment group in the first study or 
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in the HAART Care Study were excluded.  The first parent study was conducted from April 
1999 to November 2002  and included 215 HIV-infected men and women recruited from western 
Pennsylvania and eastern Ohio, university-based clinics, and comprehensive HIV care centers, as 
well as self-referral.  The continuation study (March 2004 to March 2007) consisted of 352 HIV-
infected men and women with the same inclusion and exclusion criteria as the initial parent 
study.  Out of the 35 subjects, who were randomly assigned to the usual care group in the first 
study and who also participated in the second study, just the female participants were included in 
the current study. Only their baseline data collected for the second study were used in this 
secondary data analysis in order to analyze the most recent data for each individual. 
 
3.1.3 Sample Size and Power 
 
The sample sizes for the parent studies were estimated to test the differences in mean of 
adherence over time between the intervention and usual care groups.  For the first study it was 
estimated that 100 randomly assigned participants per group (200 total) would yield a power of 
0.80 at a significance level of 0.01.  The study successfully recruited 215 subjects of which 200 
were randomized.  Power calculations for the second parent study indicated that a total of 300 
randomly assigned subjects would yield a power of 0.80 at a significance level of 0.01 to detect a 
difference in adherence response between the groups of f = .132.  A sample of 352 patients was 
enrolled in the second study.  There were 35 subjects from the second study who had also 
participated in the first study.  For these repeat participants, only the records for the second study 
were used in the current secondary data analysis, resulting in a sample size from the first study of 
180 (215 minus 35).  This 180 combined with the 352 from the second study resulted in a total 
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sample size of 532 different men and women between the two studies (1R01 NR04749 and 2R01 
NR04749, Principal Investigator, J. A. Erlen).   
 
3.2 RESEARCH DESIGN 
For this secondary analysis a cross-sectional, correlational research design was applied using 
only the baseline data pooled from the aforementioned parent studies.  Due to the fact that this 
was a secondary analysis, inclusion and exclusion criteria for this study were the same as in the 
parent studies except for gender; only women were selected for the current study.   
 
3.3 DATA COLLECTION 
 
3.3.1 Overview of Data Collection Procedures 
 
Data from the parent studies used in this secondary analysis were de-identified by the data 
manager for the parent studies.  The data from the two studies were merged and organized using 
IBM® SPSS® Statistics version 22.0 (IBM Corp., Armonk, NY).  
 
3.3.2 Data Management 
 
A software program called TELEform™ Elite (version 6.0, Cardiff Software, Inc., Vista, CA) 
was used in the parent study to design the data collection forms and for scanning the 
questionnaires, and retrieving and verifying data from the instruments.  An Oracle database 
(version 9i, Oracle Corporation, Redwood Shores, CA) was used for data storage and 
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management.  All data from the parent study were de-identified by the data manager and moved 
to a secure University of Pittsburgh server allowing only research staff access.  For the current 
study, baseline data from both parent studies for the eligible female subjects were provided to the 
investigator by the data manager and compiled to form one pooled dataset.   For this secondary 
study, data were organized and analyzed using IBM® SPSS® Statistics version 22.0 (IBM Corp., 
Armonk, NY) and Mplus version 7.31 (Muthén & Muthén 1998-2012). 
 
3.3.3 Human Subjects 
 
This study was a secondary analysis using baseline data from the two parent studies.  This study 
used only pre-existing records which were de-identified by the data manager and therefore met 
the criteria for an exempt study by the Institutional Review Board (IRB).  The researcher of this 
study received no identifying information and consequently subjects could not be identified 
either directly or indirectly from the dataset that was used.  The data could not be linked back to 
any subject identifying information in the parent study.  This study was approved by, the 







3.4.1 Overall Quality of Life 
 
The construct of overall QoL was measured with two variables from two different instruments. 
Overall QoL was measured with the Medical Outcomes Study (MOS-HIV).  The MOS-HIV is 
an instrument frequently used to measure various health outcomes for patients with HIV (Wu et 
al., 1991).  One question from the instrument addresses overall QoL:  “How has the quality of 
your life been during the past 4 weeks? That is, how have things been going for you?”    This 
item was based on a 5-point Likert scale ranging from “Very well” (1) to “Very bad” (5).  Due to 
the direction of the response, the scores were reverse-coded to indicate lower values as lower 
QoL. 
 Satisfaction with life was measured with the Satisfaction with Life Scale (SWLS).  This 
instrument is a 5-item survey representing a subject’s overall life satisfaction.  Each item was 
rated on a 7-point Likert scale ranging from 1, “strongly disagree” to 7, “strongly agree” (Diener 
et al., 1985).  In this study, Cronbach’s alpha for the satisfaction with life instrument was 0.86. 
 
3.4.2 Biological Function 
 
Biological function was represented by CD4 count and viral load.  CD4 refers to the CD4 T-
lymphocyte, a biological measurement that indicates severity of disease.  Higher count of CD4 
indicate better health, while lower count of CD4 indicate greater immune deficiency.  The CD4 
count of healthy adults range from 500 to 1200 cells/mm3.  Fewer than 200 cells/mm3 is an 
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indicator that the HIV has progressed to Stage 3 infection, which is AIDS (AIDS.gov, 2015a).  
Viral load refers to the number of HIV-1 viral particles found in each milliliter of blood.  Higher 
viral loads indicate worse disease (AIDS.gov, 2015b).  Both CD4 count and viral loads were 
obtained from the Medical Record Review (MRR) form at baseline.  When medical records were 




Depressive symptoms and fatigue were used to represent symptoms.  Depressive symptoms were 
measured using the total score of the Beck Depression Inventory II (BDI-II).  Items were rated 
on a 4-point Likert scale from 0 (least depressed) to 3 (most depressed), and the total score was 
the sum of all 21 items.  According to Beck et al. (1996), severity of depressive symptoms was 
measured as follows:  0 to 13 (“minimal”), 14 to 19 (“mild”), 20 to 28 (“moderate”), and 29 to 
63 (“severe”).  Cronbach’s alpha for the first parent study for BDI-II was 0.91 (n=215, 1R01 
NR04749).  Cronbach’s alpha for the current study was 0.92.  The energy/fatigue subscale of the 
MOS-HIV was used to measure participants’ levels of fatigue.  The subscale is comprised of four 
questions:  “How often on the past 4 weeks… Did you feel full of pep?  Did you feel worn out?  
Did you feel tired?  Did you have enough energy to do the things you wanted to do?”  Higher 
values reflect higher energy levels.  According to Wu et al. (1997), based on eight different 
studies, Cronbach’s alpha for energy/fatigue ranged from 0.78 (n=117) to 0.88 (n=1022).  





3.4.4 Functional Status 
 
Functional status was used to measure an individual’s ability to accomplish day-to-day activities, 
both social and physical. Functional status was assessed using the “Social Functioning” and 
“Physical Functioning” subscales from the MOS-HIV instrument.  Social functioning was 
measured with one question: “How much of the time, during the past month, has your health 
limited your social activities (like visiting with friends or close relatives)?”   Physical functioning 
was measured with six questions that inquired if specific physical activities had been limited 
(e.g. climbing, bending, and walking).  Subjects with higher values were better able to perform 
day-to-day activities.  According to Wu et al. (1997), based on eight different studies, 
Cronbach’s alpha for physical functioning ranged from 0.83 (n=205) to 0.89 (n=162).  For this 
current study, Cronbach’s alpha was 0.91. 
 
3.4.5 General Health Perceptions 
 
General health perceptions were measured using the “General Health” and “Mental Health” 
subscales from the MOS-HIV instrument.  General health is a self-perceived evaluation of the 
individual’s health and was measured with one question:  “In general, what would you say your 
health is?”  The Mental Health subscore of the MOS-HIV is comprised of five questions relating 
to the participant’s nervousness, calm, and happiness.  According to Wu et al. (1997), based on 
eight different studies, the alpha coefficient for mental health ranged from 0.80 (n=99) to 0.87 




3.4.6 Characteristics of the Environment 
 
Characteristics of the environment included social support and HIV stigma.  These constructs 
were measured using the total scores of the Inventory Support Evaluation List (ISEL) and the 
HIV Stigma Scale.  The Inventory Support Evaluation List (ISEL) is a 40-item instrument 
designed to measure the level of support patients receive (Cohen & Syme, 1985).  Cohen and 
Syme (1985) define social support as “the resources provided by other persons” (p. 4).  The 
items on the instrument were on a 4-point ordinal scale ranging from 0 to 3 and responses 
followed a true/false format ranging from “definitely false” to “definitely true.”  Higher scores 
indicated greater social support.  Cronbach’s alpha for this study was 0.95. 
The HIV Stigma Scale is a 40-item measure developed to assess social and emotional 
aspects of perceived HIV stigma (Berger et al., 2001). Items were ranked using a 4-point Likert 
scale ranging from 1 to 4.  Higher scores indicated greater perception of HIV stigma.  The 
instrument contained four subscales:  personalized stigma, disclosure, negative self-image, and 
perceptions of public attitudes about people living with HIV (Berger et al., 2001).  For this study, 
the total HIV stigma score was used instead of the partitioned subscales. The total HIV stigma 
score was calculated by summing the four subscales. Research has shown that the instrument 
yields a satisfactory internal consistency with a Cronbach’s alpha of 0.96 in a study of 318 






3.4.7 Characteristics of the Individual 
 
Characteristics of the individual were measured at baseline using the Socio-demographic 
Questionnaire (SDM).  The questionnaire is a 24-item self-report instrument designed by the 
Center for Research in Chronic Disorders at the University of Pittsburgh School of Nursing.   
Socio-demographic data used to assess the characteristics of the individual included age (in 
years), race (white or nonwhite), children (yes or no), marital status (partnered or not), and 
education (graduated from high school or not).  
 
 
3.5 DATA ANALYSIS 
 
3.5.1 Data Screening and Preliminary Analysis 
 
 Missing values were assessed for each of the variables.  If more than 10% of data were 
missing from a particular variable, an alternative variable was explored.  If less than 10% of data 
were missing, pairwise deletion was used (Bennett, 2001).  In the structural equation modeling 
analysis, full information maximum likelihood estimation was used to address the missing data.  
Viral load and CD4 T-cell count had the most missing values: 153 and 152 valid responses, 
respectively.  The remaining variables from the main path had between 174 and the complete 
178 responses:  overall QoL (n=176), satisfaction with life (n=176), mental health (n=175), 
general health (n=175), social functioning (n=174), physical functioning (n=176), depressive 
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symptoms (n=176), and energy/fatigue (n=175).  For the environmental factors, HIV-related 
stigma had 171 responses and social support had 176 responses.  Individual characteristics (age, 
race, education, children, and marital status) were recorded for all of the women in the sample 
(n=178). 
 All continuous variables were explored graphically in order to determine their 
distributions.  The following variables were found to deviate from a univariate normal 
distribution due to severe skewness:  CD4 count, viral load, depressive symptoms, physical 
functioning, social functioning, general health, QoL, and satisfaction with life.  Viral load was 
severely right-skewed (skewness = 6.125).  A log10 transformation was applied to viral load in an 
effort to normalize the observed data distribution.  Square root transformations were also applied 
to CD4 count, total depressive symptoms, and social functioning in an effort to approximate 
univariate normal distributions. 
 For categorical variables (race, children, education, and marital status), frequency 
distributions were assessed in order to identify any sparsely populated categories.  If distributions 
were extremely skewed with unpopulated categories, categories were meaningfully combined.  
Marital status was originally a nominal variable with seven different categories:  never married 
(35.4%), currently married (15.2%), living with partner (9%), widowed (10.7%), separated 
(7.3%), divorced (20.8%), and other (1.7%).  This variable was transformed to a dichotomous 
variable.  “Currently married” and “Living with partner” were combined to represent “Partnered” 
and all other categories were combined to signify “Not Partnered.”   Women who are 
“Partnered” potentially have help and support at home from a significant other.  However, 
women who are “Partnered” could also have the burden of caring and supporting for a sick loved 
one.  Education level was also dichotomized to depict women who did or did not graduate from 
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high school.  A very small number of women completed a higher level of education, making the 
dispersion very skewed. Participants had the following options to declare as their race:  White 
(37.6%), Black (59.6%), Latino (5.1%), American Indian (1.1%), Eskimo (0%), Pacific Islander 
(0%), Asian (0%), Unknown (5.1%), and Other (0.1%).  Because the categories other than white 
and black were so small (11%), race was dichotomized into white and non-white.   
 Data exploration was performed and graphs were plotted for each variable (box plots) 
and bivariately (scatter plots) to determine outliers or potentially influential points.  Bivariate 
correlations, variance inflation factors (VIFs), and tolerance were used to assess 
multicollinearity.  Serious multicollinearity was not present based on the following criteria: VIFs 
greater than 10 and tolerance less than 0.10 (Kline, 2011).   For individual variables, measures of 
central tendency (mean, median, and spread (standard deviation and interquartile range) were 
computed and used to identify univariate outliers for continuous type variables.  Bivariate 
scatterplots and linear regression with Mahalanobis distance were used to identify multivariate 
outliers and potentially influential points.  Mahalanobis distance was calculated for each subject 
and a histogram and box plot of these distances were plotted to reveal multivariate outliers. 
 
3.5.2 Descriptive Statistics 
 
Univariate descriptive statistics for continuous variables were calculated: mean, median, range 
(maximum and minimum values) and standard deviation.  Frequency count and percentages were 
reported for all categorical variables.  Also, since all categorical variables in this study (race, 
marital status, children, and education) were nominal variables, the mode was calculated as a 
measure of central tendency.  Bivariate descriptive statistics were represented through pairwise 
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correlations that were reported in a correlation matrix.  Pearson product-moment correlations 
were used unless non-parametric (Spearman rank-order) correlations were necessary (e.g. if data 
did not follow a bivariate normal distribution). A significance level of .05 was established a 
priori and used for two-sided hypothesis testing for all statistical tests in this study. 
 
3.5.3 Structural Equation Modeling (SEM) 
 
Structural Equation Modeling (SEM) is an approach used for a collection of statistical techniques 
that assess the relationships among latent constructs and the observed variables that represent 
them.  Latent variables are theoretical constructs, while observed or measured variables are the 
actual variables that the data represent.  For example, in this study, biological function was a 
latent variable and CD4 count and viral load were the observed variables chosen to assess 
biological function for each individual.  Table 1 shows the definitions of the latent constructs and 
observed variables that represented these constructs in this model.  Path analysis (described in 
section 3.5.4) is a type of SEM.  
Latent variable path models were developed using a two-step approach.  First, the 
measurement model was estimated and fit. Second, once the fit of the measurement model was 
determined, actual estimation of the latent variable path model was performed.  In this study, the 
latent variable path model was estimated using maximum likelihood estimation (ML) and fit was 
assessed using standard fit indices.   A model with a “good fit” met the following criteria:  a Root 
Mean Square Error of Approximation (RMSEA) less than or equal to 0.05 (“poor fit” greater 
than or equal to 0.10), a Comparative Fit Index (CFI) greater than 0.95, and a Standardized Mean 
Square Residual (SRMR) less than or equal to 0.08 (Kline, 2011).   Finally, the model chi square 
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statistic was assessed at a significance level of 0.05.   Although the sample size was near 200, the 
additional standard fit criteria were considered.  A post hoc exploratory analysis was also 
conducted.  Several modified models were created based on modification indexes, a post hoc 
technique used to add paths of a model based on the observed data (Kline, 2011).   These 
modified models were also estimated and reported.  All SEM analyses were accomplished using 
Mplus version 7.31  (Muthén & Muthén,1998-2012) structural equation modeling software. 
 
3.5.4 Path Analysis 
 
Path analysis was used to assess the relationships of multiple variables with the assumption of 
direction: causality.  For example, the first component in the model is biological function and 
there is a path that leads directly to symptoms.  Therefore, based on this model, biological 
function directly affects symptoms.  The Ferrans’ et al. revised Wilson and Cleary (2005) model 
of HRQoL is a recursive path model, meaning that its paths are unidirectional (Kline, 2011).  
Since each component of the model is a latent variable which is measured by a set of observed 
variables, this was considered to be a latent variable path model.  Standardized path coefficients 




Table 1. Theoretical and Operational Definitions of Variables 
Components of 
Model 
Theoretical Definition Operational Definition 
Biological Function “Biological function is viewed broadly and encompasses molecular, cellular, and whole 
organ level processes.” 
CD4 Count 
Viral Load 
Symptoms A symptom is defined as “a patient’s perception of an abnormal physical, emotional, or 
cognitive state.” 
• “Global measures are broad and include many varied symptoms.” 
• “Symptom-specific measures pertain to a particular symptom” (e.g. fatigue or 
anxiety or depression). 
• “The most common dimensions of symptoms that are measured include frequency, 




Functional Status  “…the ability to perform tasks in multiple domains such as physical function, social 





“…two defining characteristics of general health perceptions: (a) they integrate all the 
components that come earlier in the model, and (b) they are subjective in nature… a 
synthesis of all the various aspects of health in an overall evaluation.” 
General Health 
Mental Health 
Overall Quality of 
Life 
 “…subjective well-being related to how happy or satisfied someone is with life as a whole.” Quality of Life 
Satisfaction with Life 
Characteristics of the 
Individual 
“…categorized as demographic, developmental, psychological, and biological factors that 
influence health outcomes.” 
• Biological factors : BMI, skin color, family disease history 







Characteristics of the 
Environment 
“…are categorized as either social or physical…. Social environmental characteristics are the 
interpersonal or social influences on health outcomes, including the influence of family, 
friends, and healthcare providers… Physical environment characteristics are those settings 
such as the home, neighborhood, and workplace that influence health outcomes either 





3.6 SAMPLE SIZE AND POWER ANALYSIS 
 
Only 108 of the subjects in the second parent study (the more recent study) were female.  
In order to obtain an adequate sample size, women from the first parent study were added 
to this sample.  Out of the 532 unique subjects from the two parent studies, 178 were 
female.   According to Kline (2011), a ratio of 20:1 for number of subjects to number of 
estimated parameters is ideal for conducting a path analysis.  In the case of the primary 
analysis of this study, 14 main path coefficients were estimated.  Therefore 14 × 20 = 280 
subjects would be required for the primary aim. The study sample of 178 did not yield an 
adequate sample size to test the primary aim of this study. 
 
3.7 STUDY AIMS 
 
3.7.1 Primary Aim 
 
The primary aim of this study was to test the main path of the revised Wilson and Cleary 
HRQoL (Ferrans et al., 2005) model – the directional relationships of biological function 
(CD4 count and viral load), symptoms (depressive symptoms and energy/fatigue), 
functional status (physical functioning and social functioning), general health perceptions 
(general health and mental health), and the primary outcome variable, HRQoL (overall 
QoL and satisfaction with life).  A latent variable path analysis was used to examine the 
relationships among the five main components of the revised Wilson and Cleary model of 
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HRQoL proposed by Ferrans et al. (2005) (biological function, symptoms, functional 
status, general health status, and overall QoL).   
 
3.7.2 Secondary Aim 
 
In order to examine the relationships among the individual and environmental 
characteristics and the main components of the Ferrans’ et al. adapted HRQoL model, 
several paths were added.  The following variables were included:  age, children, race, 
education, and marital status as individual characteristics; and HIV-related stigma and 
social support as environmental characteristics. The main path portion of the Ferrans’ et 
al. (2005) adapted HRQoL model was initially expanded considering each set of 
characteristics separately and then further expanded considering both sets of 
characteristics simultaneously.  These were first accomplished separately due to the small 
sample size in this study.  
4.0 RESULTS 
 
This chapter presents the results of this study.  The first section describes the results of 
the preliminary analysis of the data.  In the next section, the study sample is described.  






4.1 PRELIMINARY ANALYSIS 
 
Box plots were plotted for each of the transformed continuous variables in order to assess 
for univariate outliers.  No extreme univariate outliers were found.  Bivariate scatterplots 
were plotted for pairs of continuous variables to check for outliers and potentially 
influential points along with linear association.  These graphs displayed no obvious 
bivariate outliers and were overall linear.  However, using Mahalanobis distance four 
multivariate outliers were identified that were not evident in the bivariate scatterplots.  
All four of these women were in the age range of 29 to 39 years old, slightly younger 
than the average age of 42 years in this sample.  Half were married at the time of the 
surveys.  Half were African American and the other half were white.  Only one of the 
four graduated from high school, which was surprising considering over half of the 
women in this sample reported finishing high school.  Not one of these four women was 
employed.  This was not atypical, because 82.6% of the women in the sample were 
unemployed.  There was only one extreme multivariate outlier (greater than three times 
the interquartile range above the 75th percentile of Mahalanobis distance).  This woman 
was African American who graduated from vocational school, and was 39 years old.  
Surprisingly, while this woman had the highest possible score for QoL (100) and a 
“minimal” score for depressive symptoms (6), she had low satisfaction with life (6) and a 





4.2 COMPARISON OF STUDIES 
 
The key study variables from the two parent studies were compared in order to ensure the 
data from the studies could be pooled (see Table 2).  The only significant differences 
found between the studies were in age (p = .001) and race (p = .006).   The women in the 
first study were slightly younger than the women in the second study (mean1 = 39.4, 
mean2 = 42.1).  In the first study, a greater percentage of women were white than in the 
second study (study1 = 50% versus study2 = 29.6%). 
Correlations among variables were mostly the same between the two studies 
(using Fisher’s r to z transformation).  The only variables that varied in relationships 
across the studies were partnership and CD4 count.  Women in the second study who 
were neither married nor living with a partner had higher mental health (r = .270, p < .01) 
and higher overall health (r = .201, p < .05).  These relationships did not hold for women 
in the first study (p = .006, p = .016, respectively).  In the first study, however, women 
who had a partner had higher (p = .019) satisfaction with life (r = -.300, p < .01), higher 
(p = .024) CD4 count (r = -.295, p < .05) and a lower (p = .026) viral load (r = -.290, p < 
.05).  In the first study, white women had higher (p = .006) CD4 count than women who 
were nonwhite (r = -.297, p < .05), although there was no association between race and 
CD4 count in the second study.   
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or n (%) 
Test 
Statistic p-value 
MOS-HIV Quality of Life (n=176) 60.7±25.3 61.8±23.2 59.9±26.7 t = 0.482 .631 
Satisfaction with Life (n=176) 17.5±7.7 17.3±7.9 17.7±7.6 t = -0.348 .729 
MOS-HIV Mental Health (n=175) 59.4±24.2 59.8±22.2 59.2±25.4 t = 0.167 .867 
MOS-HIV General Health (n=175) 46.3±24.6 47.9±22.0 45.3±26.2 t = 0.678 .499 
MOS-HIV Social Functioning 
(n=174) 
69.8±31.1 69.3±31.0 70.1±31.4 t = 0.219 .827 
MOS-HIV Physical Functioning 
(n=176) 
64.2±31.1 65.2±34.0 63.4±29.2 t = 0.373 .709 
Depressive Symptoms (BDI-II) 
(n=176) 
15.7±11.8 14.8±10.4 16.3±12.6 t = -0.600 .550 
MOS-HIV Energy/Fatigue (n=175) 48.5±23.1 47.5±21.3 49.2±24.2 t = -0.472 .638 
CD4 Count (n=152) 520.4±399.9 528.3±390.1 513.8±410.1 t = 0.330 .742 
Viral Load (log10)  (n=153) 2.725±1.2 2.855±1.3 2.616±1.9 t = 1.180 .240 
HIV Stigma (Total) (n=171) 77.0±17.9 80.2±16.8 74.8±18.3 t = 1.920 .057 
Social Support (ISEL Total) (n=176) 78.4±23.4 79.4±22.1 77.7±24.3 t = 0.493 .623 
Age  41.7±7.6 39.36±7.8 43.1±7.2 t = -3.320 .001 
White  67 (37.6) 35 (50.0) 32 (29.6) Χ2 = 7.508 .006 
Finished High School  118 (66.3) 43 (61.4) 75 (69.4) Χ2 = 1.221 .269 
Have Children  145 (81.5) 56 (80.0) 89 (82.4) Χ2 = 0.163 .686 






4.3 SAMPLE SUMMARY 
 
The women (N = 178) in this sample were, on average, 42 years old, with ages ranging 
from 24 to 61 years.  The majority of the women in the sample (59.6%) were African 
American; 37.6% of the women were white.  Latinas comprised 5.1% and American 
Indians 1.1%.  Over 80% of the women reported a religious preference:  60% were 
Protestant, 17% were Catholic, less than 1% were Jewish, and 22% reported “other.”  
Less than a quarter of the women (24.2%) were “partnered” (either currently married or 
living with a significant other).  Women who were never married accounted for 35.4%, 
while 28.1% were either separated or divorced.  Over 10% (10.7%) of the women were 
 widowed.  The majority of the women (81.5%) had children but only 41% of the women 
in the sample had at least 1 child (under the age of 18) living in the household. While 
most of the women (66.3%) finished high school and 18.5% earned a general education 
diploma (GED), only 6.2% finished 4 years of college.  Less than 2% of the sample 
finished graduate school with a masters or doctoral degree.  Women employed at the time 
of the survey comprised 17.4% of the sample and just over half of those employed 
(58.1%) worked full time.  The majority (60%) of the women were either disabled or 
unable to work.  According to the 2000 Poverty Guidelines, nearly 30% of the gross 
household incomes were below the poverty line for a family unit of two or less (under 




Table 3. Descriptive Statistics for the Sample (N=178) 
Characteristic   
 Mean SD 
MOS-HIV Quality of Life ** 60.7 25.3 
Satisfaction with Life ** 17.5 7.7 
MOS-HIV Mental Health ** 59.4 24.2 
MOS-HIV General Health ** 46.3 24.6 
MOS-HIV Social Functioning ** 80.0* 31.1 
MOS-HIV Physical Functioning ** 64.2 31.1 
Depressive Symptoms (BDI-II) ** 13.0* 11.8 
MOS-HIV Energy/Fatigue ** 48.5 23.1 
CD4 Count ** 422.5* 399.9 
Viral Load ** 400.0* 278,868.4 
Viral Load (log10) ** 2.7 1.2 
HIV Stigma (Total) ** 77.0 17.9 
Social Support (ISEL Total) ** 78.4 23.4 
Age  41.7 7.6 
 n % 
White  67  37.6 
Finished High School  118 66.3 
Have Children  145 81.5 
Partnered 43 24.2 
*Median, ** n < 178  
 
4.4 RESULTS OF CORRELATION ANALYSES 
Bivariate correlation analyses confirmed many of the expected associations among the 
measured variables in the revised model of health-related quality of life (HRQoL) (see 
Table 3).  Overall QoL was positively correlated with general health (r = .537, p < .01) 
and mental health (r = .612, p < .01).  Satisfaction with life had a positive relationship 
with overall health (r = .412, p < .01) and mental health (r = .530, p < .01).  Overall 
general health was also found to have a positive association with social functioning (r = -
.486, p < .01) and physical functioning (r = .516, p < .01).  (Social functioning was not 
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measured in the same direction as the other variables; higher social functioning values 
represent lower social functioning.  Therefore, negative correlations actually signify a 
positive relationship.) Mental health had a positive relationship with social functioning (r 
= -.515, p < .01) and physical functioning (r = .424, p < .01).  Social functioning was 
negatively associated with both depressive symptoms (r = .435, p < .01) and 
energy/fatigue (r = .596, p < .01).  Physical functioning also had a negative relationship 
with depressive symptoms (r = -.331, p < .01) and energy/fatigue (r = -.548, p < .01).  
Depressive symptoms had no significant correlation with either viral load or CD4 count 
(p ≥ .05).  Energy/fatigue also had no significant correlation with either CD4 count or 
viral load (p ≥ .05). 
 Social support had positive associations with overall QoL (r = .413, p < .01), 
satisfaction with life (r = .406, p < .01), general health (r = .338, p < .01), mental health (r 
= .642, p < .01), physical (r =.209, p < .05) and social (r = -.407, p < .01) functioning.  
Social support had negative relationships with depressive symptoms (r = -0.558, p < .01) 
and energy/fatigue (r = -.483, p < .01).  Social support had no significant correlation with 
CD4 count (r = .066, p > .05), but did have a significant negative correlation with viral 
loads (r = -.165, p < .05).  HIV-related stigma had negative correlations with overall QoL 
(r = -.462, p < .01), satisfaction with life (r = -.498, p < .01), general health (r = -.492, p < 
.01), mental health (r = -.601, p < .01), physical (r = -.260, p < .01) and social (r = .369, p 
< .01) functioning.  HIV stigma did not have a statistically significant association with 
either CD4 count or viral load.  HIV-related stigma did, however, have positive 
relationships with both depressive symptoms (r = .592, p < .01) and energy/fatigue (r = 
.522, p < .01). 
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 The only individual characteristic that was significantly associated with any 
variables of interest in the model was race.  Race was found to have a positive correlation 
with both social functioning (r = .179, p < .05) and overall QoL (r = .194, p < .05), 
suggesting that white women had both a lower QoL and lower social functioning than 




Table 4. Correlations among Study Variables, Overall and by Study 
 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 
1    .451** .612** .537** -.425** .350** -.457** .499** .017 -.062 -.462** .413** -.017 .194* -.052 -.119 -.032 
371B  372B   373B.640** 374B.648** 375B.564** 376B-.366** 377B.412** 378B-.399** 379B.429** 380B.200 381B-.181 382B-.462** 383B.413** 384B-.128 385B.233 386B-.055 387B-.140 388B-.221 
389B  390B   391B.344** 392B.601** 393B.535** 394B-.498** 395B.339** 396B-.557** 397B.562** 398B-.090 399B-.008 400B-.443** 401B.342** 402B.033 403B.084 404B-.084 405B-.035 406B.089 
407B2 408B    409B.530** 410B.412** 411B-.193* 412B.191* 413B-.515** 414B.332** 415B.128 416B-.123* 417B-.498** 418B.406** 419B.022 420B.021 421B-.069 422B-.105 423B-.098 
424B  425B    426B.559** 427B.308** 428B-.165 429B.199 430B-.409** 431B.239* 432B.126 433B-.130 434B-.479** 435B.351** 436B-.194 437B.084 438B-.060 439B-.048 440B-.300* 
441B  442B    443B.517** 444B.499** 445B-.291** 446B.281** 447B-.611** 448B.481** 449B.159 450B-.147 451B-.469** 452B.412** 453B.098 454B-.001 455B-.030 456B-.123 457B.059 
458B3 459B     460B.605** 461B-.515** 462B.424** 463B-.734** 464B.685** 465B.124 466B-.257** 467B-.601** 468B.642** 469B.135 470B.103 471B-.113 472B-.090 473B.095 
474B  475B     476B.584** 477B-.478** 478B.403** 479B-.720** 480B.554** 481B.104 482B-.313** 483B-.590** 484B.561** 485B.004 486B.082 487B-.016 488B.004 489B-.154 
490B  491B     492B.621** 493B-.533** 494B.470** 495B-.768** 496B.793** 497B.171 498B-.224* 499B-.598** 500B.645** 501B.092 502B.101 503B-.186 504B-.036 505B.270** 
506B4 507B      508B-.486** 509B.516** 510B-.558** 511B.637** 512B.176* 513B-.059 514B-.492** 515B.338** 516B-.009 517B.105 518B-.090 519B.050 520B.043 
521B  522B      523B-.494** 524B.472** 525B-.536** 526B.557** 527B.171 528B-.147 529B-.470** 530B.229 531B.038 532B.098 533B.111 534B.172 535B-.172 
536B  537B      538B-.573** 539B.636** 540B-.604** 541B.694** 542B.203 543B-.031 544B-.508** 545B.370** 546B-.173 547B.083 548B-.179 549B-.053 550B.201* 
551B  552B       553B-.571** 554B.435** 555B-.596** 556B-.081 557B.129 558B.369** 559B-.407** 560B-.083 561B-.179* 562B.012 563B.019 564B-.015 
565B  566B       567B-.580** 568B.355** 569B-.634** 570B-.143 571B-.257* 572B.431** 573B-.413** 574B-.024 575B-.192 576B.034 577B-.034 578B.160 
579B  580B       581B-.599** 582B.542** 583B-.553** 584B.016 585B-.037 586B.349** 587B-.355** 588B.028 589B-.149 590B.018 591B.098 592B-.186 
593B6 594B        595B-.331** 596B.548** 597B.078 598B-.103 599B-.260** 600B.209* 601B-.036 602B.158 603B-.159 604B.109 605B-.071 
606B  607B        608B-.299* 609B.567** 610B.075 611B-.166 612B-.241* 613B.245* 614B-.100 615B.085 616B-.097 617B.127 618B-.180 
619B  620B        621B-.440** 622B.555** 623B.113 624B-.086 625B-.273** 626B.206* 627B-.103 628B.184 629B-.166 630B.045 631B.098 
632B7 633B         634B-.557** 635B-.065 636B.144 637B.592** 638B-.558** 639B-.159 640B-.040 641B-.006 642B.081 643B-.025 
644B  645B         646B-.540** 647B-.137 648B.336** 649B.601** 650B-.436** 651B-.135 652B.028 653B-.209 654B.000 655B.133 
656B  657B         658B-.621** 659B-.031 660B.007 661B.579** 662B-.563** 663B-.042 664B-.130 665B.140 666B.128 667B-.128 
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668B  669B          670B.041 671B-.154 672B-.522** 673B.483** 674B.118 675B.165* 676B-.054 677B.004 678B.140 
679B  680B          681B-.040 682B-.203 683B-.409** 684B.320** 685B.079 686B.101 687B.157 688B.120 689B-.012 
690B  691B          692B.127 693B-.121 694B-.566** 695B.550** 696B-.015 697B.175 698B-.175 699B.016 700B.243* 
701B9 702B           703B-.412** 704B-.073 705B.066 706B.076 707B-.041 708B-.097 709B.032 710B-.107 
711B  712B           713B-.441** 714B-.077 715B.126 716B.007 717B-.297* 718B.043 719B.056 720B-.295* 
721B  722B           723B-.440** 724B-.061 725B.043 726B.097 727B.146 728B-.157 729B.017 730B.071 
731B 0 732B            733B.134 734B-.188* 735B-.157 736B.007 737B.142 738B.010 739B.091 
740B  741B            742B.247* 743B-.182 744B-.090 745B.154 746B.051 747B-.014 748B-.293* 
749B  750B            751B.003 752B-.168 753B-.173 754B-.056 755B.110 756B.030 757B-.032 
758B11 759B             760B-.500** 761B-.074 762B-.022 763B.089 764B.086 765B-.070 
766B  767B             768B-.550** 769B.026 770B-.156 771B.003 772B-.068 773B.122 
774B  775B             776B-.478** 777B-.037 778B.061 779B.117 780B.100 781B-.223* 
782B12 783B              784B.116 785B.152 786B-.108 787B-.091 788B.086 
789B  790B              791B.082 792B.278* 793B-.097 794B-.039 795B-.159 
796B  797B              798B.057 799B.077 800B-.077 801B-.043 802B.314** 
803B13 804B               805B.020 806B-.020 807B-.126 808B.005 
809B  810B               811B.002 812B-.120 813B-.120 814B-.025 
815B  816B               817B-.013 818B.054 819B-.094 820B-.049 
821B 4 822B                823B-.083 824B-.138 825B.107 
826B  827B                828B-.088 829B-.214 830B.000 
831B  832B                833B-.098 834B-.020 835B.194* 
836B15 837B                 838B-.022 839B-.033 
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840B  841B                 842B-.029 843B-.096 
844B  845B                 846B-.043 847B-.080 
848B16 849B                  850B-.015 
851B  852B                  853B.031 
854B  855B                  856B.043 
857B17 858B                   
859B  860B                   
861B  862B                   
1 Overall Quality of Life, 2 Satisfaction with Life, 3 Mental Health, 4 General Health, 5 Social Functioning, 6 Physical Functioning, 7 Depressive Symptoms, 8 Energy/Fatigue, 9 CD4 
Count, 10 Viral Load, 11 HIV-related Stigma, 12 Social Support, 13 Age, 14 White Race, 15 Finished High School, 16 Have Children, 17 Married or Partnered.  ** p < 0.01, * p < 0.05.    





4.5 STRUCTURAL EQUATION MODELING RESULTS 
 
863BTo address the aims of this study, structural equation modeling (SEM) was used to 
conduct latent variable path analysis, where both measurement and structural linear 
relations are considered.  Unfortunately, problems were encountered with the 
estimation/fitting of the underlying measurement model.  The fitting of the                   
model for the original latent variable path analysis model specified, which included two 
observed/measured variables for each latent variable of main path model, resulted in 
some parameter estimates that were inadmissible.  Specifically, the latent variables of 
symptoms and general health perceptions had an inadmissible correlation of -1.123, 
indicating a problem with estimation (correlations should be between -1 and 1).  In 
addition, the measured variable of energy/fatigue was more strongly correlated with both 
measured variables of the latent variable of general health perceptions, overall general 
health and mental health, than with the latent variable of symptoms.  Accordingly, several 
simplified path models were considered.  Observed variable path models using only a 
single observed variable to represent each latent construct (viral load, depressive 
symptoms, physical functioning, overall general health, and overall QoL) and hybrid 
models, which included both latent and observed variables, with only biological function 
configured as a latent variable and measured by viral load and CD4 count, were fit to 
provide insight into further model development and model modifications (suggested 
through post hoc analysis).  The hybrid model was also considered as nearly 15% of 
values from CD4 count and viral load were missing.  Having two indicators reflecting a 
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single latent variable strengthens the construct.  Each indicator represents a different 
aspect (i.e. CD4 count or viral load) of the latent construct and the combination of the 
two makes the latent factor more reliable.  All of the models that were considered with 
their fit statistics and indices are reported in Table 4. 
 
4.5.1 Model Fit 
864BAs displayed in Figure 4, the first model, an observed variable path model using viral 
load (log base 10 transformed), depressive symptoms (square root transformed), physical 
functioning, general health, and overall QoL and no characteristics of the individual or 
environment, demonstrated a poor fit (X2 = 50.529, df=6, p < .001, RMSEA = .222, CFI 
= .727, SRMR =.321).  In addition to the results of hypothesis testing supporting poor 
model fit, the Root Mean Square Error of Approximation (RMSEA) was higher than the 
suggested maximum 0.10, the Comparative Fit Index (CFI) was lower than the suggested 
minimum 0.95, and the Standardized Root Mean Square Residual (SRMR) was higher 
than the suggested maximum 0.08 indicating a “poor fit” (Kline, 2011).  All standardized 
paths in the model were significant (highest p-value, p = .048).  The strongest 
standardized path coefficient was the path connecting physical functioning with general 




6BFigure 4. Main Observed Variable Path Model using Observed Variables 
866B ased on the model modification indexes (MI), a path was added post hoc from 
depressive symptoms to general health (Figure 5).  This modified model demonstrated an 
improved fit from the first model (X2 = 10.598, df = 5, p = .060, RMSEA = .086, CFI = 
.966, SRMR = .043), with only the RMSEA exceeding the maximum suggested threshold 
for a “good fit”.  All paths in this modified model were significant (highest p-value, p = 
.048).  The strongest standardized path coefficient was that of overall QoL on general 
health (β = .527, p < .001). 
867B  
7BFigure 5. Modified Main Observed Variable Path Model with a Path Added from 




868BThe hybrid model included the observed variables of depressive symptoms, 
physical functioning, general health and overall QoL and the latent variable of biological 
function, which was measured by two observed variables, viral load and CD4 count 
(Figure 6).  This model was poor fitting (X2 = 69.6, df=9, p < .001, RMSEA = .194, CFI 
= .754, SRMR = .112); however, all paths, other than the path for depressive symptoms 
on biological function, were statistically significant (p < 05).  The standardized path 
coefficient of general health on physical functioning had the strongest path coefficient in 
this model (β = .564, p < .001). 
869B  
8BFigure 6. Main Path Model using Biological Function as a Latent Variable 
 
870BThis model was also modified post hoc based on MI and a path was added from 
depressive symptoms to general health (Figure 7).  Again, this modified model did not fit 
well (X2 = 23.375, df = 8, p = .003, RMSEA = .104, CFI = .938, SRMR = .052).  All 
paths were significant other than the path from biological function to depressive 
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symptoms (p = .131).  The strongest standardized path coefficient was again that for 
overall QoL on general health (β = .546, p < .001). 
871B  
9BFigure 7.  Modified Main Path Model using Biological Function as a Latent Variable and 
Adding a Path from Depressive Symptoms to General Health 
 
872B ased on the MI, another model was created with two additional paths from 
depressive symptoms to general health and also from depressive symptoms to overall 
QoL (Figure 8).  The RMSEA, the CFI, and the SRMR were all within the thresholds 
suggesting a good model fit (X2 = 9.887, df = 7, p = .195, RMSEA = .048, CFI = .988, 
SRMR = .036).  Only the standardized path coefficient from biological function to 




10BFigure 8. Modified Main Path Model with Biological Function as a Latent Variable and 
with Paths Added from Depressive Symptoms to General Health and to Overall Quality 
of Life 
 
874BIn Figure 9, individual characteristics (age, children, partnered, finished high 
school, and race) were simultaneously added to the original observed variable path 
model.  In this figure, only statistically significant paths involving individual 
characteristics were reported, although all paths were included in the model.  This model 
demonstrated a lack of fit (X2 = 63.8, df = 6, p < .001, RMSEA = .233, CFI = .735, 
SRMR = .068), according to the chi-squared statistic, RMSEA, CFI, and the SRMR.  
Also, the only individual characteristic significantly contributing to the prediction of any 
of the main pathway components was age.  Only the standardized path coefficient from 
age to viral load was statistically significant (γ = -.169, p = .033).  The largest path 
coefficient in this model was from physical functioning to general health (β = .565, p < 
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.001).  In this model, the path coefficient from viral load to depressive symptoms was not 
significant (γ = .196, p = .069). 
875B  
11BFigure 9.  Observed Variable Main Path Model with Individual Characteristics 
  
876BWhen the model was modified post hoc adding a path from depressive symptoms 
to general health (Figure 10) based on MI, the model fit improved (X2 = 14.901, df = 5, p 
= .011, RMSEA = .105, CFI = .955, SRMR = .026) with only the chi-squared statistic 
and the RMSEA fit index suggesting a poor fit for the modified path model.  The path 
between age and viral load remained significant (γ = -.169, p = .035).  In this modified 





12BFigure 10.  Modified Main Observed Variable Path Model with Individual Factors and a 
Path Added from Depressive Symptoms to General Health 
 
878BIn Figure 11, the environmental characteristics (social support and HIV stigma) 
were both added to the model of the observed variables: viral load, depressive symptoms, 
physical functioning, general health, and overall QoL.  The SRMR indicated a good 
model fit; however, the chi-squared statistic, RMSEA and CFI did not (X2 = 25.41, df = 
6, p < .001, RMSEA = .138, CFI = .935, SRMR = .043).  In this model, the paths for the 
environmental factors of social support and HIV-related stigma to either viral load or 
physical functioning were not significant.  Also, the path from social support to general 
health was not significant.  The only relationship in the main path that was not significant 
was between depressive symptoms and viral load (γ = .046, p = .489).  The path 
coefficient from depressive symptoms to physical functioning was -.325 (p < .001).  The 
strongest relation in this model was between physical functioning and general health 
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(β=.463, p < .001).  The path between general health and overall QoL was .416 (p < 
.001). 
879B  
13BFigure 11.  Main Observed Variable Path Model with Environmental Characteristics 
 
880B ased on the modification indices, adding a path from depressive symptoms to 
general health (Figure 12) improved the overall model fit (Χ2= 5.947, df = 5, p = .311, 
RMSEA = .033, CFI = .997, SRMR = .019) according to all the standard fit indices and 
the chi-squared test statistic.  In this figure, only statistically significant paths involving 
environmental characteristics were reported, although all paths were included in the 
model.  In this model, the paths between social support and depressive symptoms (β= -
.303, p < .001) and overall QoL (β = .150, p = .034) were significant.  HIV-related stigma 
had significant paths to every component other than viral load (p = .429) and physical 




14BFigure 12. Modified Main Observed Variable Path Model with Environmental 
Characteristics and Path Added from Depressive Symptoms to General Health 
 
882BThe hybrid path model with the latent variable of biological function and 
including all of the individual factors (Figure 13) also did not fit well (X2 = 73.64, df = 
14, p < .001, RMSEA = .155, CFI = .762, SRMR = .068).  There was a significant path 
between age and biological function (β = .182, p = .045) and a trend (.05 < p < .10) for 
the path from age to physical functioning (β = -.129, p = .054).  There were also trends 
for the paths for physical functioning on both education (β =.129, p = .057) and race (β = 




15BFigure 13. Main Path Model with Individual Characteristics and Biological Function as a 
Latent Variable 
 
884BFigure 14 represents the model modified post hoc based on MI, where a path 
between depressive symptoms and general health was added to the path model including 
the latent variable of biological function and the remaining observed variables 
(depressive symptoms, physical functioning, general health, and QoL).  While this model 
fit based on standard fit indices (Χ2= 24.736, df = 13, p = .025, RMSEA = .071, CFI = 
.953, SRMR = .033), the only individual factor with a significant path was age, which 




16BFigure 14. Modified Main Path Model with Individual Factors and Biological Function 
as a Latent Variable and Path Added from Depressive Symptoms to General Health 
 
886BFigure 15 illustrates the hybrid path model where the environmental factors were 
simultaneously added.  Only SRMR (.046) indicated that this model was a good fit (Χ2 = 
32.504, df = 11, p < .0001, RMSEA = .107, CFI = .934).  The paths connecting social 
support and HIV-related stigma to depressive symptoms and QoL were significant.  Also, 
the path connecting HIV-related stigma to general health was significant (γ = -.339, p < 
.001).  The strongest path coefficient in this model connected general health and physical 




18BFigure 15. Main Path Model with Environmental Characteristics with Biological 
Function as a Latent Variable 
 
887BFigure 16 illustrates another modified model, explored post hoc based on MI.  A 
path from depressive symptoms to general health was added to the model that included 
environmental factors and biological function as a latent variable.  The chi-squared test 
and all fit indices showed that this model had a good fit (Χ2 = 13.04, df = 10, p = .221), 
RMSEA = .042, CFI = .991, SRMR = .029).  In this model, both environmental factors 
had significant paths with depressive symptoms and overall QoL.  Also, there was a 
significant path between HIV-related stigma and general health (γ = -.214, p = .002).   
The path added post hoc from general health to depressive symptoms was also significant 
(β = -.238, p < .001).  In this model the strongest path coefficient represented the relation 




20BFigure 16. Modified Main Path Model with Environmental Characteristics with 
Biological Function as a Latent Variable and Path Added from Depressive Symptoms to 
General Health 
 
888BThe full observed variable path model including both individual and 
environmental characteristics  (Figure 17) demonstrated a good fit according only to the 
SRMR (Χ2 = 26.635, df = 6, p < 0.001, RMSEA =.142, CFI =.932, SRMR =.027).  As for 
many of the previous models involving either individual or environmental characteristics, 
the path from age to viral load was the only significant path from the individual 
characteristics to the components of the main observed variable path model (γ = -.176, p 
= .002).  Both environmental characteristics had significant paths only to depressive 
symptoms and QoL.  Also, HIV-related stigma had a significant path to general health (γ 




21BFigure 17. Main Observed Variable Path Model with Individual and Environmental 
Characteristics 
 
 890BAnother post hoc modified model was explored based on MI, adding a path to this 
full, observed path model between depressive symptoms and general health (Figure 18).   
This modified model fit well according to the chi-squared test statistic and all fit statistics 
and indices (Χ2 = 5.04, df = 5, p = .411, RMSEA = .007, CFI = 1.000, SRMR = .011).  





22BFigure 18. Modified Main Observed Variable Path Model with Individual and 
Environmental Characteristics and Path Added from Depressive Symptoms to General 
Health 
 
 892BFinally, a hybrid path model with all environmental and individual factors and 
biological function as the only latent variable was fit (Figure 19).  This model 
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demonstrated a good fit based on only the SRMR index (Χ2 = 35.50, df = 16, p = .003, 
RMSEA = .084, CFI = .941, SRMR = .031). 
 
 893B  
23BFigure 19. Main Path Model with Individual and Environmental Characteristics with 




24BTable 5. Structural Equation Model and Path Analysis Results 
Model N RMSEA CFI SRMR Χ2 df p 
Main Path Model using 
Observed Variables 
151 .222 .727 .121 50.5 6 <.0001 
Modified Main Path Model with 
a Path Added from Depressive 
Symptoms to General Health 
151 .086 .966 .043 10.6 5 .060 
Main Path Model using 
Biological Function as a Latent 
Variable 
178 .194 .754 .112 69.6 9 <.0001 
Modified Main Path Model 
using Observed Variables and 
Biological Function as a Latent 
Variables with a Path Added 
from Depressive Symptoms to 
General Health 
178 .104 .938 .052 23.4 8 .003 
Modified Main Path Model 
using Observed Variables and 
Biological Function as a Latent 
Variable with Paths Added from 
Depressive Symptoms to 
General Health and from 
Depressive Symptoms to 
Overall Quality of Life 
178 .048 .988 .036 9.9 7 .195 
Main Path Model using 
Observed Variables with 
Individual Characteristics 
178 .233 .735 .068 63.8 6 <.0001 
Modified Main Path Model 
using Observed Variables with 
Individual Characteristics with a 
Path Added from Depressive 
Symptoms to General Health 
178 .105 .955 .026 14.9 5 .011 
Main Path Model using 
Observed Variables with 
Environmental Characteristics 
171 .138 .935 .043 25.4 6 <.001 
Modified Main Path Model 
using Observed Variables with 
Environmental Characteristics 
with a Path Added from 
Depressive Symptoms to 
General Health 
171 .033 .997 .019 5.9 5 .311 
Main Path Model using 
Observed Variables and 
Biological Function as a Latent 
Variable with Individual 
Characteristics 
178 .155 .762 .068 73.6 14 <.0001 
Modified Main Path Model 
using Observed Variables with 
Individual Characteristics and 
Biological Function as a Latent 
Variable with a Path Added 
178 .071 .953 .033 24.7 13 .025 
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from Depressive Symptoms to 
General Health 
Main Path Model using 
Observed Variables and 
Biological Function as a Latent 
Variable with Environmental 
Characteristics 
171 .107 .934 .046 32.5 11 <.001 
Modified Main Path Model 
using Observed Variables and 
Biological Function as a Latent 
Variable with Environmental 
Characteristics and a Path 
Added from Depressive 
Symptoms to General Health 
171 .042 .991 .029 13.04 10 .221 
Main Path Model using 
Observed Variables with 
Individual and Environmental 
Characteristics 
171 .142 .932 .027 26.6 6 <.001 
Modified Main Path Model 
using Observed Variables with 
Individual and Environmental 
Characteristics and a Path 
Added from Depressive 
Symptoms to General Health 
171 .007 1.00 .011 5.0 5 .411 
Main Path Model using 
Observed Variables and 
Biological Function as a Latent 
Variable with Individual and 
Environmental Characteristics 
171 .084 .941 .031 35.5 16 .003 
RMSEA: Root Mean Square Error of Approximation 
CFI: Comparison Fit Index 
SRMR: Standardized Mean Square Residual 
 
4.5.2 Strength of Relationships 
894BThe main aims of this study were focused on testing the revised Wilson and Cleary model 
of HRQoL (Ferrans et al., 2005) in women with HIV.  The primary aim was to examine 
the relationships among the five central components of the model (biological function, 
symptoms, functional status, general health perceptions, overall QoL).  The secondary 
aim was to examine the relationships among the individual (i.e. age, children, race, 
marital status, education) and environmental (i.e. HIV-related stigma, social support) 
characteristics that may impact biological function, symptoms, functional status, general 
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health perceptions, and overall QoL among women living with HIV infection.  Although 
many models were explored in the previous section, only the observed variable path 
models will be described here because they adequately address the research aims.  The 
main path model (Figure 5) with paths connecting viral load, depressive symptoms, 
physical functioning, overall general health, and overall QoL addressed the primary aim.  
The secondary aim was addressed using the full, observed variable path model (Figure 
17) including all of the individual characteristics and environmental characteristics.  
 895BIn the model assessing only the main path among the five components (Figure 4), 
all of the path coefficients were significant.  The path between depressive symptoms and 
viral load was .157 (p = .048), indicating a relatively weak, positive relationship between 
biological function and symptoms.  The path between physical functioning and 
depressive symptoms was slightly stronger and negative (β = -.356, p < 0.001).  The 
strongest path coefficient in the model connected overall general health with physical 
functioning (β = .530, p < .001), indicating a moderate positive relationship between 
general health and functional status.  The last path in this model demonstrated a moderate 
positive relationship between overall QoL and general health (β = .526, p < .001). 
 896BIn the post hoc modified model with a path added from depressive symptoms to 
overall general health, the path coefficients remained nearly the same (Figure 5).  In this 
model, however, the strongest path coefficient connected overall general with overall 
QoL (β = .527, p < .001).  The path coefficient between depressive symptoms and overall 
general health indicated a moderate, negative relationship (β = -.438, p < .001). 
 897BIn the full path model (Figure 17) including individual and environmental 
characteristics, many path coefficients were not statistically significant.  The main path in 
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this model was similar to the previous model (with only the five main components); 
however, the relationship between depressive symptoms and viral load was not 
significant (γ = .031, p = .656). The path coefficient between physical functioning and 
depressive symptoms was -.350 (p < .001), indicating a significant weak to moderate 
negative association between functional status and symptoms.  Again, the strongest path 
coefficient in the model was between general health and physical functioning and was 
positive (β = .460, p < .001).  Overall QoL and general health shared a moderately strong 
positive path coefficient of .412 (p < .001).   
898BThe only significant path coefficient in this model that connected any of the 
individual factors to the main components was the path between age and viral load; this 
was a weak, negative relationship (γ = -.176, p = .027).  There were, however, several 
path trends between demographic variables and the main model components.  Path 
coefficients connecting physical functioning with age (γ = -.118, p = .087), children (γ = -
.121, p = .08), education (γ = .130, p = .058), and race (γ = -.129, p = .065) all with p-
values less than 0.10.   There was also a path trend between overall QoL and whether or 
not a woman was partnered (γ = .104, p = .090). 
899BWhile many path coefficients between environmental factors and the main 
components in the model were significant, the strongest paths were linked to depressive 
symptoms.  Depressive symptoms shared a moderately strong positive path coefficient (γ 
= .426, p < .001) with HIV-related stigma and a moderately negative path coefficient (γ = 
-.310, p < .001) with social support.  Path coefficients connecting overall QoL and 
environmental factors were weak.  The path between overall QoL and HIV-related stigma 
was weak and negative (γ = -.172, p = .023), while the path between overall QoL and 
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social support was weak and positive (γ = .145, p = .039).  While there was no significant 
path between general health and social support, the path coefficient between HIV-related 
stigma and general health was moderately strong and negative (γ = -.341, p < .001).   
900BIn the post hoc modified model with both environmental and individual 
characteristics and a path added from depressive symptoms to overall general health, the 
path coefficients did not significantly change.  While in the previous model (not 
modified), there was a significant pathway coefficient connecting age and viral load, this 
relationship was not present in the modified model.  The strongest path coefficient in the 
main components of the model was the relationship between overall QoL and overall 
general health (β = .412, p < .001).  Of all the environmental and individual 
characteristics, the pathway connecting HIV-related stigma and depressive symptoms 
was the strongest (γ = .426, p < .001).  Finally, the path coefficient of depressive 
symptoms and overall general health was moderately negative (β = -.349, p < .001), 
implying that increased depressive symptoms are associated with decreased overall 
general health.   
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5.0 SUMMARY AND CONCLUSIONS 
 
901BThis chapter presents a summary of the findings from this study.  Interpretation and 
discussion of the results, conclusions, and implications for nursing research are also 
addressed in this section.   
 
5.1 STUDY SUMMARY 
 
902BThe current study was a secondary analysis using a cross-sectional, correlational research 
design to test the revised Wilson and Clearly model of health-related quality of life 
(HRQoL) (Ferrans et al., 2005) in women living with HIV/AIDS in western Pennsylvania 
and eastern Ohio.  This study used baseline data pooled from two independent 
randomized controlled trials (R01 NR04749, Adherence to Protease Inhibitors and 
Quality of Life, and 2R01 NR04749, Improving Adherence to Antiretroviral Therapy, 
Principal Investigator, J. A. Erlen). The first parent study tested the efficacy of a nurse-
delivered, telephone-based, cognitive-behavioral program designed to enhance adherence 
to antiretroviral therapy (ART) in both men and women living with HIV from April 1999 
to November 2002 (R01 NR04749, Principal Investigator, J. A. Erlen).  Subjects were 
randomly assigned to one of two treatment groups: intervention plus usual care or usual 
care only.  The main aim of this parent study was to test the efficacy of the structured 
intervention compared to usual care on ART adherence over time.  The secondary aim of 




903BThe second parent study. a continuation of the first parent study (from March 
2004 to March 2007), added an individualized intervention as a third treatment arm 
(2R01 NR04749, Principal Investigator, J. A. Erlen).  As in the first parent study, 
participants were randomly assigned to one of three treatment groups:  structured 
intervention, individualized intervention, and usual care (control).   The primary aim of 
the second parent study was to test the efficacy of the structured and individual ART-
adherence interventions compared to usual care over time.   The secondary aim of that 
study, as in the first parent study, focused on examining the associations of ART 
adherence with clinical response and HRQoL. 
904BThe primary aim of the current study was to test the main path of the revised 
Wilson and Cleary model of HRQoL (Ferrans et al., 2005).  This model proposed 
directional relationships of five constructs: biological function, symptoms, functional 
status, general health perceptions, and the primary outcome variable, HRQoL.  To 
operationalize this model biological function was measured using CD4 count and viral 
load.  Symptoms were measured using depressive symptoms and energy/fatigue.  
Functional status was measured using physical and social functioning.  General health 
perceptions was measured using overall general health and mental health.  HRQoL was 
measured using overall QoL and satisfaction with life.  The secondary aim of this study 
was to test the full revised Wilson and Cleary model of HRQoL (Ferrans et al., 2005), 
adding environmental characteristics (HIV-related stigma and social support) and 
individual characteristics (age, race, education, children, and marital status).  The sample 
included 178 unique women living with HIV/AIDS who participated in the parent 
studies.   
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905BIn order to test the primary and secondary aims of the current study, structural 
equation modeling (SEM) and path analysis were performed.  Bivariate correlations were 
assessed to test relationships among the variables in the model.  Also, differences 
between the samples of the two parent studies were examined using the unpaired t-test for 
quantitative variables and the chi-square test for nominal variables.  Results from these 




5.2.1 Sample Characteristics 
906BIn this study, 106 of the women were African American (59.6%); 67 women were white 
(36.7%).  According to the CDC, HIV diagnosis rates are highest for African American 
women.  In 2010, 64% of newly infected women were African American and only 18% 
were white (CDC 2014b).  The diagnosis rate of HIV in African American women (38.1 
out of 100,000 women) is estimated to be 20 times that of white women (CDC 2015b). 
Previous studies have also included a large proportion of African American women.  In 
studies conducted by Andrinopoulos et al. (2011) and Vyavaharkar et al. (2012), the 
participants were also mostly African American women (73% and 85.2% respectively).  
907BThe women in the current study were on average 42 years old, which was also 
congruent with previous studies.  In a study by Logie et al. (2013), the average age of the 
173 HIV/AIDS infected women who participated in this study was 40.7 years.  
Vyavaharkar et al. (2012) conducted a study using 399 female participants with 
HIV/AIDS; their mean age was 41.5 years.   
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908BTwo-thirds of the women in the current study finished high school, which was 
similar to prior published reports.  In two studies that included both men and women with 
HIV/AIDS, nearly three-quarters of the participants had a high school or higher level of 
education (Galvan et al., 2008; White et al., 2012).  Of the women in the study by Logie 
et al. (2008), 69.4% had attained at least a high school education.    
909BOnly 24.2% of the women in this sample were partnered.  Relationship status in 
this study was consistent with the sample of women in several other studies where less 
than 35% of women were married, in a relationship, or living with a partner (Logie et al., 
2013; Vyavaharkar et al., 2012; White et al., 2012).  The majority of the women who 
participated in this study had children (81.5%) but only 41% of these women had 
children living in their households.  In the study by Logie et al. (2013), 67.9% of the 
women were caring for (or supporting) children.  According to Abrefa-Gyan et al. (2015), 
people who have children and lower levels of social support have a lower QoL.  In this 
study, only 17.4% of the women were employed.  This finding is congruent with the 
literature, where several teams of researchers reported between 17% and 37% of women 
living with HIV/AIDS were employed (Messer et al., 2013; Psaros et al., 2012; 
Vyavarharkar et al., 2012; Webel & Higgins, 2012).  Blalock et al. (2002) reported that 
people living with HIV who are employed have a significantly higher QoL than those that 
are unemployed. 
 
5.2.2 Association of Variables 
34BPrior to testing the primary and secondary aims focusing on the revised Wilson and 
Cleary model (Ferrans et al., 2005) of HRQoL, the bivariate relationships among the 
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components of the model were explored (see Table 3).   As expected, women with better 
overall health and mental health had better HRQoL and satisfaction with life.  Higher 
levels of functioning, both social and physical, were associated with higher overall 
general health and mental health.  Women with higher physical and social functioning 
had better mental health and perceived general health.  Higher levels of depressive 
symptoms and lower energy levels were associated with lower functioning.  These 
findings support associations reported in the literature.  For example, in a study assessing 
life satisfaction in HIV positive women in Nepal, Eller and Mahat (2007) showed that life 
satisfaction was positively associated with physical functioning, social functioning, and 
mental health.  In another study assessing physical functioning, Clingerman (2003) 
showed that, in a sample of 70 men and 8 women, weekly vigorous activity duration was 
positively associated with overall health status.  In a study with both men and women 
living with HIV/AIDS, White et al. (2012) found that people with higher levels of 
depressive symptoms had lower physical functioning.  In a study on 278 women from the 
rural southeastern United States, Moneyham et al. (2005) showed that daily functioning 
was significantly and negatively associated with depressive symptoms. 
35BSurprisingly, biological function was not associated with symptoms in this study.  
There was no relationship between CD4 count or viral load and depressive symptoms and 
energy/fatigue, which supports prior findings.  Basavaraj et al. (2010) reported that CD4 
count and viral load are associated with symptoms such as insomnia and pain.  However, 
work by Barroso et al. (2010) showed that there is no significant association between 
physiological variables such as viral load or CD4 count and fatigue.  A possible 
explanation could be that symptoms such as fatigue and pain are reflected at a later point 
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in time than when the blood samples are drawn for CD4 count and viral load.  Changes in 
CD4 count and viral load may possibly predict symptoms that occur in the future.  In this 
study, blood levels were obtained from patients’ medical records or obtained through 
self-report.  Therefore, CD4 count and viral load were not measured at the same time the 
self-report assessments were completed.  Timing of the assessments could have been a 
factor in the lack of relationship demonstrated in this study between biological function 
and depressive symptoms and fatigue.  Another explanation for the lack of relationships 
seen with depressive symptoms and fatigue could be that depressive symptoms and 
fatigue do not best describe “symptoms” for a woman living with HIV.  
 36BGreater social support was related to higher QoL, increased satisfaction with life, 
better general and mental health, improved physical and social functioning, less 
depressive symptoms, and higher energy levels in women in this study.  These results are 
congruent with the findings in the literature that social support is an important factor in 
the overall health and QoL of a woman living with HIV/AIDS.  The literature suggests 
that people living with HIV/AIDS who have better social support have higher HRQoL 
(Clingerman, 2003; Clum et al., 2009; Colbert et al., 2010; Cowdery & Pesa, 2002; 
Vyavaharkar et al., 2012; White et al., 2012).  Women who have adequate support from 
family and friends might be more likely to adhere to drug treatment regimens, attend 
regular doctor appointments, and consequently their QoL might improve.  Social support 
has also been shown to mediate the relationship between HIV symptoms and depressive 
symptoms in women living with HIV (Moneyham et al., 2005). 
37BHIV-related stigma, on the other hand showed a negative association with a 
woman’s overall health.  Women with higher levels of HIV-related stigma had more 
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depressive symptoms, more fatigue, worse physical and social functioning, lower general 
and mental health, and decreased satisfaction with life and overall HRQoL.  These 
findings support prior research where HIV-related stigma was shown to have a negative 
effect on many aspects of a woman’s health such as higher levels of depression 
(Vyavaharkar et al., 2012; Logie et al., 2013) and lower levels of HRQoL (Vyavaharkar 
et al., 2012).  Studies by both Logie et al. (2013) and White et al. (2012) demonstrated 
that HIV-related stigma is significantly positively associated with depression. 
Vyavaharkar et al. (2012) found that in rural women, there was a significant negative 
association between perceived and internalized stigma and QoL.  Logie et al. (2013) used 
a revised version of the HIV-related stigma scale (which was used in the current study) 
(Berger et al., 2001), while White et al. (2012) and Vyavaharkar et al. (2012) used a 
perceived stigma scale (Sowell et al., 1997).  Even though the researchers used different 
tools to assess stigma, the findings are similar. 
 
5.2.3 Path Analysis 
910BThe primary aim of this study was to test the main path of the revised Wilson and Cleary 
model of HRQoL (Ferrans et al., 2005).  Structural equation modeling was employed to 
conduct an observed variable path analysis for the main five components of the 
conceptual model: biological function as identified by viral load, symptoms as depressive 
symptoms, functional status as physical functioning, general health perceptions as overall 
general health, and HRQoL as overall QoL.  This observed variable path model did not 
demonstrate a good fit (Figure 4).  However, the post hoc modified model that included 
an additional path from depressive symptoms to overall general health was a good fit 
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(Figure 5).  While the modified model was exploratory and added post hoc, results 
confirmed hypothesized correlations among the variables that represented the five main 
components of the model as reported in the literature.  The relationship between viral 
load and depressive symptoms was positive, indicating that women with higher viral 
loads had increased depressive symptoms.   As expected, depressive symptoms and 
physical functioning had an inverse relationship; women with higher depressive 
symptoms exhibited lower physical functioning.   Women who had greater physical 
functioning had better overall general health perceptions.  Finally, as expected, women 
who reported higher general health perceptions reported higher overall QoL.  In a study 
that combined 917 men and women (did not specify how many of each), Sousa et al. 
(2006) had similar results using a latent variable path SEM model to test the original 
Wilson and Cleary model (1995) of HRQoL.  The analysis in the Sousa et al. (2006) 
study resulted in an exploratory post hoc modified path model with paths added from 
symptoms to both general health perceptions and overall QoL.    
 911BThe secondary aim of this study was to test the entire revised Wilson and Cleary 
model of HRQoL (Ferrans et al., 2005) by including the individual and environmental 
characteristics with the five main components.  The full, observed path model (Figure 17) 
that considered individual factors (age, race, children, education, and marital status) and 
environmental factors (HIV-related stigma and social support) did not demonstrate a 
good fit.  Again, a modified model with a good fit was generated post hoc, adding a path 
from depressive symptoms to overall general health (Figure 18).  In this modified model, 
path coefficients yielded nearly the same results as in the previous model (the main 
observed path model with individual and environmental characteristics, Figure 17).  The 
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only difference was that viral load did not have a significant path to depressive 
symptoms.  In another study testing a modified version of the Wilson and Cleary model 
(1995) using 348 men and women, Vidrine et al. (2005) assessed behavioral factors and 
socio-economic factors as environmental and individual characteristics.  While socio-
economic status and behavior had significant associations with HRQoL, neither 
symptoms nor functional status had significant associations with HRQoL (Vidrine et al., 
2005).  The main path in the Vidrine et al. (2005) model was not consistent with the main 
path of the current study.  The Vidrine et al. (2005) model, as stated previously, was a 
modified version of the original Wilson and Cleary (1995) model.  In this modified 
model, the general health component was removed so that there was a direct path from 
functional status (role-specific) to QoL.  Consequently, the main path consisted of: 
disease status, symptoms, role function, and generic QoL.    
912BIn the full, observed variable path model, paths from individual and 
environmental characteristics were assessed on each of the main components.  The only 
demographic (individual) characteristic that had any relation with the main components 
of the model was age.  Age and the biological factor viral load shared a significant 
negative path, indicating that the older a woman, the lower her viral load.  A possible 
explanation for this finding could be that as women age, they become more concerned 
about their health and more responsible for their health-care regimens (i.e. taking 
medication and seeking help); however, there is very limited literature supporting a link 
between age and viral load.    One study examining the association between age and viral 
load in 135 men and women living with HIV found that people who are older (greater 
than 50 years) have lower plasma viral load (Goodkin et al., 2004).  Goodkin et al. (2004) 
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provided a possible explanation, stating that immunological differences between age 
groups could be the cause of the different viral load levels.  These researchers also 
showed that older people had higher CD4 count than those who were younger (Goodkin 
et al., 2004).  This study did not specifically examine this relationship in women.  
913BWhile both environmental factors (HIV-related stigma and social support) were 
found to relate to depressive symptoms and overall QoL, they had no relationship with 
either viral load or physical functioning.  Also, HIV-related stigma had a negative 
relationship with overall general health.  There was no significant path coefficient 
between social support and overall general health.  HIV-related stigma and social support 
may have a greater influence on a woman’s emotional and psychological well-being as 
opposed to her physical well-being.  As expected and as reported in the literature, HIV-
related stigma had a negative association with general health perceptions and overall QoL 
(Vyavaharkar et al., 2012), while social support was positively associated with these 
variables (Cowdery & Pesa, 2002; Vyavaharkar et al., 2012).  Vyavaharkar et al. (2012) 
showed that in a sample of rural women with HIV, both perceived and internal stigma 
had a negative association with QoL and perceived social support had a positive 
association with QoL.  Cowdery and Pesa (2002) found that social support had a positive 
association with both mental health and general health perceptions in women living with 
HIV.   Social support was found to be the strongest predictor of mental health scores 
(Cowdery and Pesa, 2002).  In the current study, social support had the strongest 
relationship with mental health (r = .642, p < .01).   
914BWhile the proposed observed path models created for both the primary and 
secondary aims of this study did not adequately fit, the modified path models are consistent 
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with Wilson and Cleary’s original conceptual model of HRQoL (1995); however, in the 
modified path models, many path coefficients lacked statistical significance.  Although the 
diagram depicts only paths from one component to the next, according to Wilson and 
Cleary, the factors in the models can have relationships “at every level of the model, 
although they are not represented in the Figure” (Wilson and Cleary, 1995, p. 63).  To 
support that statement, this study demonstrated that the addition of the path from depressive 
symptoms to overall general health in both the main path model (Figure 5) and the full 
model (Figure 18) indicates that depressive symptoms not only are significantly related to 
a woman’s functioning, but may also be related to a woman’s overall general health.  The 
literature has also shown that higher levels of depressive symptoms contribute to a lower 




915BThere were several limitations to this study.  First, the fact that this was a secondary 
analysis raised several issues.   The first issue was the timeframe of the parent studies.  
The first parent study began in 1999 and ended in 2002 and the second parent study 
started five years later in 2004 and ended in 2007..  This time span could have 
contributed to significant differences between the samples of women due to advances in 
drug treatment therapy.  Therefore, the samples of the two studies were carefully 
examined prior to this secondary analysis to confirm that the data from the studies could 
be pooled.  At the outset, the second parent study had a larger proportion of female 
African American participants (11% more).  Also, participants in the second study were 
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slightly older than the first (3.7 year difference between the means).  HIV-related stigma 
was slightly higher (p = .057) in the second study than in the first.  All means of the 
variables were similar between the two studies (there were no significant differences 
between means of the two parent studies for any other measure of interest).  The samples 
from the two parent studies were too small for a multiple sample approach.   
916BAnother possible limitation could have stemmed from the fact that subjects were 
recruited from the community; therefore, the investigators were not able to access 
medical records when subjects were not recruited directly from clinics.  This inability to 
access records contributed to the incomplete data for biological function (viral load and 
CD4 count) even though there was an attempt to collect these data from the participants 
via self-report.  Because this was a secondary analysis, measures were limited to the 
instruments used in the parent study.  For example, the MOS-HIV scale was used for 
several of the observed variables in the model: energy/fatigue for symptoms, social and 
physical functioning, overall general health and mental health for general health 
perceptions, and overall QoL.  Recall that the original measurement model proposed for 
this study was problematic.  There were issues concerning several of the latent variables.  
It is possible that selecting different instruments might better represent these theoretical 
constructs.  An alternative instrument used in the literature to measure symptoms is the 
Revised Sign and Symptom Check-list for HIV (SSC-HIVrev) (Holzemer et al., 2001).  
There is also an alternative instrument used to measure HRQoL called the Chronic Illness 
Quality of Life Ladder (CIQOLL).  This instrument has several subscales including but 
not limited to physical and emotional domains and also has a time element (present, past, 
future, and life before diagnosis of HIV) (Murdaugh et al., 2006).   
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917BThis study used a cross-sectional research design, and only included the baseline 
data for each of the measures.  Cross-sectional designs are limited because causation 
cannot be established between the variables. Additionally, changes over time in the 
variables cannot be assessed. Even though there was a time lapse between the two parent 
studies, the women who participated in both studies had prior exposure to and completed 
the same instruments used for analysis in the current study.  It is possible that women 
who participated in both studies were sensitized to the measure.  Since only the most 
recent responses (from the second parent study) were used in the current study, there 
could be some bias for the responses for women who repeated the study.  The most 
significant limitation of this study was the sample size.  Only 178 unique women 
participated in the two parent studies; if a woman was eligible and participated in both 
studies, only her data from the most recent measures were used in this analysis.  This 
total number of subjects was not an adequate sample size for the latent variable path 
analysis proposed to address the two research aims.  A minimum of 280 subjects would 
have been needed to test the primary aim.  Lastly, the sample of this secondary analysis 
was limited to women in western Pennsylvania and eastern Ohio and may not be 
generalizable to other populations of women living with HIV/AIDS, nationally and 
internationally.  In 2010, 64% of newly infected women in the United States were 
African Americans, 18% were Whites, and 15% were Hispanics/Latinas (CDC, 2014b).  
In this sample, only 5.1% of the women were Latinas.  This could be attributed to the 







918BFurther research focused on assessing the relationships among a woman’s HRQoL and 
other health constructs (such as depression, mental health, pain, energy levels, coping, 
risk behavior, functioning, and worry) would contribute to the field of nursing and 
healthcare.  Such research would need to involve examining these relationships 
temporally, using a longitudinal study approach as opposed to a cross-sectional analysis.  
A study with a longitudinal design assessing HRQoL constructs over time would help to 
clarify causation.  Further research expanding the regions from which the sample is 
drawn would help to confirm that the revised Wilson and Cleary (Ferrans et al., 2005) 
model of HRQoL can be generalized.  This approach would suggest a need for a multi-
site study.  Based on the findings of the current study, future studies might also benefit by 
using different instruments, such as the Revised Sign and Symptom Check-list for HIV 
(SSC-HIVrev) for symptoms or the Chronic Illness Quality of Life Ladder (CIQOLL) for 
HRQoL. Finally, the selection of different observed variables to represent the theoretical 
constructs might better represent the revised Wilson and Cleary model of HRQoL 
(Ferrans et al., 2005). Based on the post hoc modified models in this study, paths were 
created relating depressive symptoms to overall general health.  It is possible that 
depressive symptoms reflect a woman’s emotional or psychological well-being more so 
than they represent a woman’s biological or physiological symptoms.  Depressive 
symptoms were more strongly correlated with both mental health (r = -.734, p < .01) and 
overall general health (r = -.558, p < .01) than they were with energy/fatigue (r = -.557, p 
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< .01).  An alternative measurement model might include depressive symptoms within 
the latent construct of overall general health perceptions.  Testing the revised Wilson and 
Cleary model of HRQoL (Ferrans et al., 2005) using a larger, more diverse sample of 
women from a broader geographic region over a specified period of time has the potential 
to yield important findings for healthcare providers and researchers.   
919BDepressive symptoms were identified as an important factor in a woman’s 
physical health and general health perceptions.  The strong relationship between 
depressive symptoms and a woman’s HRQoL was also reflected in the literature 
(Andrinopoulos et al., 2011; Holtz et al., 2014; Vyavaharkar et al. 2011).  Since the 
women in this study with lower depressive symptoms had both higher physical 
functioning and better overall general health, designing and testing interventions to 
alleviate depressive symptoms need to be developed.   In a study in Thailand focused on 
127 pregnant adult women, high self-esteem, high emotional support and low physical 
symptoms were associated with lower levels of depressive symptoms (Ross et al., 2009).  
Based on the positive association of social support and negative association of HIV-
related stigma on depressive symptoms, developing and testing programs to increase 
social support and decrease HIV-related stigma may decrease symptoms of depression 
and consequently improve a woman’s HRQoL.  More research is needed to explore the 
physical and psychosocial aspects that influence the HRQoL of women living with 
HIV/AIDS in the United States.  Confirmation of these relationships can provide 





5.5 CONCLUSION  
 
920BThe primary focus of this study was to test the revised Wilson and Cleary model of 
HRQoL (Ferrans et al., 2005) on women living with HIV/AIDS.  The original Wilson 
and Cleary model of HRQoL (1995) has been tested on people (men and women) living 
with HIV/AIDS (Sousa et al., 2006; Vidrine et al., 2005); however, prior to this study the 
revised model had not yet been assessed for only women living with HIV/AIDS.  Despite 
its limitations, the findings from this study suggest that the revised Wilson and Cleary 
model of HRQoL (Ferrans et al., 2005), with a post hoc modification connecting 
symptoms to general health perceptions, has been supported in a sample of HIV-infected 
women from western Pennsylvania and eastern Ohio.  While the full, modified model fit, 
evidence from this study suggests that individual characteristics do not have an influence 
(based on the lack of significant path coefficients) on components of HRQoL in women 
living with HIV.   On the other hand, results from this study suggest that environmental 
characteristics do have an influence on a woman’s HRQoL.  Based on this study, many 
health-related components contribute either positively or negatively to a woman’s 
HRQoL.  Women with lower viral loads, lower depressive symptoms, lower HIV-related 
stigma, higher social support, higher physical functioning, and higher overall general 
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